0001417398--09-302025Q1FALSEP12MP3Y440,000xbrli:sharesiso4217:USDiso4217:USDxbrli:shareshi:segmentxbrli:pureiso4217:EUR00014173982024-10-012024-12-3100014173982025-01-3100014173982023-10-012023-12-3100014173982024-12-3100014173982024-09-3000014173982023-09-3000014173982023-12-310001417398us-gaap:CommonStockMember2024-09-300001417398us-gaap:AdditionalPaidInCapitalMember2024-09-300001417398us-gaap:RetainedEarningsMember2024-09-300001417398us-gaap:TreasuryStockCommonMember2024-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001417398us-gaap:NoncontrollingInterestMember2024-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001417398us-gaap:NoncontrollingInterestMember2024-10-012024-12-310001417398us-gaap:RetainedEarningsMember2024-10-012024-12-310001417398us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001417398us-gaap:TreasuryStockCommonMember2024-10-012024-12-310001417398us-gaap:CommonStockMember2024-12-310001417398us-gaap:AdditionalPaidInCapitalMember2024-12-310001417398us-gaap:RetainedEarningsMember2024-12-310001417398us-gaap:TreasuryStockCommonMember2024-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001417398us-gaap:NoncontrollingInterestMember2024-12-310001417398us-gaap:CommonStockMember2023-09-300001417398us-gaap:AdditionalPaidInCapitalMember2023-09-300001417398us-gaap:RetainedEarningsMember2023-09-300001417398us-gaap:TreasuryStockCommonMember2023-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001417398us-gaap:NoncontrollingInterestMember2023-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001417398us-gaap:NoncontrollingInterestMember2023-10-012023-12-310001417398us-gaap:RetainedEarningsMember2023-10-012023-12-310001417398us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310001417398us-gaap:TreasuryStockCommonMember2023-10-012023-12-310001417398us-gaap:CommonStockMember2023-12-310001417398us-gaap:AdditionalPaidInCapitalMember2023-12-310001417398us-gaap:RetainedEarningsMember2023-12-310001417398us-gaap:TreasuryStockCommonMember2023-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001417398us-gaap:NoncontrollingInterestMember2023-12-310001417398us-gaap:SegmentDiscontinuedOperationsMemberhi:BatesvilleMember2023-02-010001417398us-gaap:SegmentDiscontinuedOperationsMemberhi:BatesvilleMember2023-02-012023-02-0100014173982022-07-012024-12-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398srt:AmericasMemberhi:MilacronMember2024-10-012024-12-310001417398srt:AmericasMember2024-10-012024-12-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398srt:AmericasMemberhi:MilacronMember2023-10-012023-12-310001417398srt:AmericasMember2023-10-012023-12-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398srt:AsiaMemberhi:MilacronMember2024-10-012024-12-310001417398srt:AsiaMember2024-10-012024-12-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398srt:AsiaMemberhi:MilacronMember2023-10-012023-12-310001417398srt:AsiaMember2023-10-012023-12-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2024-10-012024-12-310001417398hi:EuropeTheMiddleEastAndAfricaMember2024-10-012024-12-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2023-10-012023-12-310001417398hi:EuropeTheMiddleEastAndAfricaMember2023-10-012023-12-310001417398hi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398hi:MilacronMember2024-10-012024-12-310001417398hi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398hi:MilacronMember2023-10-012023-12-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2024-10-012024-12-310001417398us-gaap:TransferredAtPointInTimeMember2024-10-012024-12-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2023-10-012023-12-310001417398us-gaap:TransferredAtPointInTimeMember2023-10-012023-12-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2024-10-012024-12-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2024-10-012024-12-310001417398us-gaap:TransferredOverTimeMember2024-10-012024-12-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2023-10-012023-12-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2023-10-012023-12-310001417398us-gaap:TransferredOverTimeMember2023-10-012023-12-310001417398hi:TerraSourceHoldingsLLCMember2024-12-310001417398hi:SupplierFinanceProgramMember2024-12-310001417398hi:SupplierFinanceProgramMember2024-09-300001417398us-gaap:TradeAccountsReceivableMember2024-10-012024-12-310001417398us-gaap:TradeAccountsReceivableMember2023-10-012023-12-310001417398us-gaap:TradeAccountsReceivableMember2024-12-310001417398us-gaap:TradeAccountsReceivableMember2024-09-300001417398srt:MinimumMember2024-12-310001417398srt:MaximumMember2024-12-310001417398us-gaap:CustomerRelationshipsMember2024-12-310001417398us-gaap:CustomerRelationshipsMember2024-09-300001417398us-gaap:TradeNamesMember2024-12-310001417398us-gaap:TradeNamesMember2024-09-300001417398us-gaap:TechnologyBasedIntangibleAssetsMember2024-12-310001417398us-gaap:TechnologyBasedIntangibleAssetsMember2024-09-300001417398us-gaap:ComputerSoftwareIntangibleAssetMember2024-12-310001417398us-gaap:ComputerSoftwareIntangibleAssetMember2024-09-300001417398us-gaap:TradeNamesMember2024-12-310001417398us-gaap:TradeNamesMember2024-09-300001417398hi:ProcessEquipmentGroupSegmentMember2024-12-310001417398hi:ProcessEquipmentGroupSegmentMember2024-09-300001417398hi:MoldingTechnologySolutionsMember2024-12-310001417398hi:MoldingTechnologySolutionsMember2024-09-300001417398hi:ProcessEquipmentGroupMember2024-09-300001417398hi:MilacronMember2024-09-300001417398hi:ProcessEquipmentGroupMember2024-12-310001417398hi:MilacronMember2024-12-310001417398hi:FormerCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2022-06-080001417398us-gaap:LineOfCreditMember2024-12-310001417398us-gaap:LineOfCreditMember2024-09-300001417398hi:FourthAmendedAndRestatedCreditAgreementMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2022-06-080001417398us-gaap:SecuredDebtMember2024-12-310001417398us-gaap:SecuredDebtMember2024-09-300001417398hi:A185EuroTermLoanMemberus-gaap:LineOfCreditMember2023-06-210001417398hi:TermLoan225MillionMemberhi:TermLoanMember2024-12-310001417398hi:TermLoan225MillionMemberhi:TermLoanMember2024-09-300001417398hi:TwentyTwentyFourSeniorUnsecuredNotesDueFebruaryTwentyTwentyNineMemberus-gaap:SeniorNotesMember2024-02-140001417398hi:A4000SeniorUnsecuredNotesMember2024-12-310001417398hi:A4000SeniorUnsecuredNotesMember2024-09-300001417398hi:A2019NotesMemberus-gaap:SeniorNotesMember2019-09-250001417398hi:A350MillionSeniorUnsecuredNotesMember2024-12-310001417398hi:A350MillionSeniorUnsecuredNotesMember2024-09-300001417398hi:A350MillionSeniorUnsecuredNotesMember2021-03-030001417398us-gaap:UnsecuredDebtMember2024-12-310001417398us-gaap:UnsecuredDebtMember2024-09-300001417398us-gaap:NotesPayableOtherPayablesMember2024-12-310001417398us-gaap:NotesPayableOtherPayablesMember2024-09-300001417398hi:DebtInstrumentTrancheOneMemberus-gaap:LineOfCreditMember2024-12-310001417398hi:DebtInstrumentTrancheTwoMemberus-gaap:LineOfCreditMember2024-12-310001417398us-gaap:LineOfCreditMember2024-10-012024-12-310001417398us-gaap:LineOfCreditMember2023-10-012023-12-310001417398hi:DebtInstrumentTrancheOneMemberus-gaap:SecuredDebtMember2024-12-310001417398hi:DebtInstrumentTrancheTwoMemberus-gaap:SecuredDebtMember2024-12-310001417398hi:DebtInstrumentTrancheOneMemberus-gaap:LongTermDebtMember2024-12-310001417398hi:DebtInstrumentTrancheOneMemberus-gaap:LongTermDebtMember2023-12-310001417398hi:A200TermLoanAnd185TermLoanMember2024-12-310001417398hi:OtherFinancingAgreementsMember2024-12-310001417398hi:OtherFinancingAgreementsMember2024-09-300001417398hi:LGFacilityAgreementAmendmentMember2024-12-310001417398country:US2024-10-012024-12-310001417398country:US2023-10-012023-12-310001417398us-gaap:ForeignPlanMember2024-10-012024-12-310001417398us-gaap:ForeignPlanMember2023-10-012023-12-310001417398us-gaap:PerformanceSharesMember2024-10-012024-12-310001417398us-gaap:PerformanceSharesMember2023-10-012023-12-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001417398us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-09-300001417398us-gaap:ParentMember2024-09-300001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-10-012024-12-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2024-10-012024-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-10-012024-12-310001417398us-gaap:ParentMember2024-10-012024-12-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-12-310001417398us-gaap:ParentMember2024-12-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001417398us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-09-300001417398us-gaap:ParentMember2023-09-300001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-10-012023-12-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2023-10-012023-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-10-012023-12-310001417398us-gaap:ParentMember2023-10-012023-12-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-12-310001417398us-gaap:ParentMember2023-12-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310001417398hi:TimeBasedStockAwardsMember2024-10-012024-12-310001417398us-gaap:PerformanceSharesMember2024-10-012024-12-310001417398hi:GeneralClaimsAndLawsuitMembersrt:MinimumMember2024-10-012024-12-310001417398hi:MoldingTechnologySolutionsMember2024-09-300001417398hi:MoldingTechnologySolutionsMember2024-12-310001417398us-gaap:FairValueInputsLevel1Member2024-12-310001417398us-gaap:FairValueInputsLevel2Member2024-12-310001417398us-gaap:FairValueInputsLevel3Member2024-12-310001417398us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberus-gaap:LineOfCreditMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberus-gaap:LineOfCreditMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberus-gaap:SecuredDebtMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberus-gaap:SecuredDebtMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberus-gaap:SecuredDebtMember2024-12-310001417398hi:OneHundredEightyFiveMillionEuroTermLoanMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-12-310001417398hi:A2021NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2021NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberhi:A2021NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2021NotesMember2024-12-310001417398hi:A2020NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2020NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberhi:A2020NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2020NotesMember2024-12-310001417398hi:A2019NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2019NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel2Memberhi:A2019NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2019NotesMember2024-12-310001417398us-gaap:FairValueInputsLevel1Member2024-09-300001417398us-gaap:FairValueInputsLevel2Member2024-09-300001417398us-gaap:FairValueInputsLevel3Member2024-09-300001417398us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberus-gaap:LineOfCreditMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberus-gaap:LineOfCreditMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberus-gaap:SecuredDebtMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberus-gaap:SecuredDebtMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberus-gaap:SecuredDebtMember2024-09-300001417398hi:OneHundredEightyFiveMillionEuroTermLoanMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:OneHundredEightyFiveMillionEuroTermLoanMember2024-09-300001417398hi:A2021NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2021NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberhi:A2021NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2021NotesMember2024-09-300001417398hi:A2020NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2020NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberhi:A2020NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2020NotesMember2024-09-300001417398hi:A2019NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2019NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel2Memberhi:A2019NotesMember2024-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2019NotesMember2024-09-300001417398us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-06-210001417398hi:SchenckProcessFoodAndPerformanceMaterialsMember2023-09-010001417398us-gaap:CrossCurrencyInterestRateContractMember2024-10-012024-12-310001417398us-gaap:CrossCurrencyInterestRateContractMember2023-10-012023-12-310001417398us-gaap:CrossCurrencyInterestRateContractMember2024-12-310001417398us-gaap:CrossCurrencyInterestRateContractMember2024-09-300001417398us-gaap:ForeignExchangeForwardMember2024-12-310001417398us-gaap:ForeignExchangeForwardMember2024-09-300001417398hi:ProcessEquipmentGroupSegmentMember2024-10-012024-12-310001417398hi:ProcessEquipmentGroupSegmentMember2023-10-012023-12-310001417398us-gaap:OperatingSegmentsMemberhi:ProcessEquipmentGroupSegmentMember2024-10-012024-12-310001417398us-gaap:OperatingSegmentsMemberhi:ProcessEquipmentGroupSegmentMember2023-10-012023-12-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2024-10-012024-12-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2023-10-012023-12-310001417398us-gaap:CorporateNonSegmentMember2024-10-012024-12-310001417398us-gaap:CorporateNonSegmentMember2023-10-012023-12-310001417398country:US2024-10-012024-12-310001417398country:US2023-10-012023-12-310001417398country:DE2024-10-012024-12-310001417398country:DE2023-10-012023-12-310001417398country:CN2024-10-012024-12-310001417398country:CN2023-10-012023-12-310001417398country:IN2024-10-012024-12-310001417398country:IN2023-10-012023-12-310001417398hi:InternationalMember2024-10-012024-12-310001417398hi:InternationalMember2023-10-012023-12-310001417398us-gaap:OperatingSegmentsMemberhi:ProcessEquipmentGroupSegmentMember2024-12-310001417398us-gaap:OperatingSegmentsMemberhi:ProcessEquipmentGroupSegmentMember2024-09-300001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2024-12-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2024-09-300001417398us-gaap:CorporateNonSegmentMember2024-12-310001417398us-gaap:CorporateNonSegmentMember2024-09-300001417398country:US2024-12-310001417398country:US2024-09-300001417398country:DE2024-12-310001417398country:DE2024-09-300001417398country:CN2024-12-310001417398country:CN2024-09-300001417398country:IN2024-12-310001417398country:IN2024-09-300001417398hi:InternationalMember2024-12-310001417398hi:InternationalMember2024-09-300001417398hi:MilacronInjectionMoldingBusinessMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:SubsequentEventMember2025-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 

FORM 10-Q
 
☒ Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the quarterly period ended December 31, 2024

OR

 ☐ Transition Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the transition period from _____ to _____

Commission File Number. 001-33794 
HILLENBRAND, INC.
(Exact name of registrant as specified in its charter)
Indiana 26-1342272
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
One Batesville Boulevard  
Batesville,IN 47006
(Address of principal executive offices) (Zip Code)
(812) 931-5000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, without par valueHINew York Stock Exchange
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer ☐Emerging growth company☐
Non-accelerated filer☐Smaller reporting company☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒ 

The registrant had 70,420,357 shares of common stock, no par value per share, outstanding as of January 31, 2025.


HILLENBRAND, INC.
INDEX TO FORM 10-Q
 
  Page
  
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
  
   
   
   
 
1
PART I — FINANCIAL INFORMATION

Item 1.                FINANCIAL STATEMENTS
 
Hillenbrand, Inc.
Consolidated Statements of Operations (Unaudited)
(in millions, except per share data)
 
Three Months Ended
December 31,
 20242023
Net revenue$706.9 $773.3 
Cost of goods sold471.9 522.3 
Gross profit235.0 251.0 
Operating expenses171.1 157.9 
Amortization expense25.2 25.5 
Pension settlement (gain) charge(1.7)8.3 
Interest expense, net25.1 29.8 
Income from continuing operations before income taxes15.3 29.5 
Income tax expense6.4 10.0 
Income from continuing operations8.9 19.5 
Loss from discontinued operations (net of income tax expense)— (0.3)
Consolidated net income8.9 19.2 
Less: Net income attributable to noncontrolling interests2.5 2.0 
Net income attributable to Hillenbrand$6.4 $17.2 
Earnings per share
Basic earnings per share
Income from continuing operations attributable to Hillenbrand$0.09 $0.25 
Income from discontinued operations— — 
Net income attributable to Hillenbrand$0.09 $0.25 
Diluted earnings per share
Income from continuing operations attributable to Hillenbrand$0.09 $0.25 
Loss from discontinued operations— (0.01)
Net income attributable to Hillenbrand$0.09 $0.24 
Weighted average shares outstanding (basic)70.6 70.3 
Weighted average shares outstanding (diluted)70.6 70.5 

See Condensed Notes to Consolidated Financial Statements


2
Hillenbrand, Inc.
Consolidated Statements of Comprehensive (Loss) Income (Unaudited)
(in millions)
 
Three Months Ended
December 31,
 20242023
Consolidated net income$8.9 $19.2 
Changes in other comprehensive (loss) income, net of tax:
Currency translation adjustment (1)
(63.9)49.3 
Pension and postretirement0.8 6.0 
Change in net unrealized gain on derivative instruments27.9 0.9 
Total changes in other comprehensive (loss) income, net of tax(35.2)56.2 
Consolidated comprehensive (loss) income (26.3)75.4 
Less: Comprehensive income attributable to noncontrolling interests1.9 2.0 
Comprehensive (loss) income attributable to Hillenbrand$(28.2)$73.4 
 
(1)Includes gains and losses on intra-entity foreign currency transactions that are of a long-term investment nature.

See Condensed Notes to Consolidated Financial Statements

3
Hillenbrand, Inc.
Consolidated Balance Sheets
(in millions)
December 31, 2024 (unaudited)September 30,
2024
ASSETS  
Current Assets  
Cash and cash equivalents$208.0 $199.3 
Trade receivables, net309.5 350.1 
Receivables from long-term manufacturing contracts, net289.5 302.7 
Inventories, net521.7 525.2 
Prepaid expenses and other current assets134.0 132.6 
Total current assets1,462.7 1,509.9 
Property, plant, and equipment, net303.7 316.6 
Operating lease right-of-use assets, net157.8 168.7 
Intangible assets, net1,229.4 1,285.9 
Goodwill1,779.1 1,835.7 
Other long-term assets126.7 121.9 
Total Assets$5,059.4 $5,238.7 
LIABILITIES  
Current Liabilities  
Trade accounts payable$405.3 $444.8 
Liabilities from long-term manufacturing contracts and advances293.8 315.2 
Current portion of long-term debt20.9 20.6 
Accrued compensation93.1 122.0 
Other current liabilities276.6 286.5 
Total current liabilities1,089.7 1,189.1 
Long-term debt1,885.0 1,872.4 
Accrued pension and postretirement healthcare102.0 109.3 
Operating lease liabilities131.8 141.1 
Deferred income taxes295.5 314.3 
Other long-term liabilities139.0 155.1 
Total Liabilities$3,643.0 $3,781.3 
Commitments and contingencies (Note 13)
SHAREHOLDERS’ EQUITY  
Common stock, no par value (75.8 and 75.8 shares issued, 70.4 and 70.2 shares outstanding)
— — 
Additional paid-in capital707.6 712.6 
Retained earnings1,035.5 1,045.2 
Treasury stock (5.4 and 5.6 shares, at cost)
(230.6)(238.2)
Accumulated other comprehensive loss(131.2)(96.6)
Hillenbrand Shareholders’ Equity1,381.3 1,423.0 
Noncontrolling interests35.1 34.4 
Total Shareholders’ Equity1,416.4 1,457.4 
Total Liabilities and Shareholders’ Equity$5,059.4 $5,238.7 
 
See Condensed Notes to Consolidated Financial Statements
4
Hillenbrand, Inc.
Consolidated Statements of Cash Flows (Unaudited)
(in millions)
Three Months Ended
December 31,
 20242023
Operating activities from continuing operations  
Consolidated net income$8.9 $19.2 
Adjustments to reconcile income from continuing operations to used in operating activities:
   Total loss from discontinued operations (net of income tax expense)— 0.3 
Depreciation and amortization37.9 38.8 
Deferred income taxes(4.8)(22.4)
Amortization of deferred financing costs1.2 1.1 
Share-based compensation4.7 5.2 
Trade accounts receivable, net and receivables from long-term manufacturing contracts17.2 36.7 
Inventories, net(13.3)(1.7)
Prepaid expenses and other current assets(3.6)(22.0)
Trade accounts payable(23.8)(38.9)
Liabilities from long-term manufacturing contracts and advances,
accrued compensation, and other current liabilities(25.8)(57.7)
Income taxes payable(8.9)14.9 
Accrued pension and postretirement(0.5)6.5 
Other, net(0.5)(4.0)
   Net cash used in operating activities from continuing operations(11.3)(24.0)
Investing activities from continuing operations  
Capital expenditures(10.2)(12.4)
Proceeds from sales of property, plant, and equipment0.5 0.1 
Cross-currency swap settlement9.1 — 
Collection of deferred purchase price receivables10.1 — 
Other, net— (2.8)
Net cash provided by (used in) investing activities from continuing operations9.5 (15.1)
Financing activities from continuing operations  
Repayments on long-term debt(4.9)(2.5)
Proceeds from revolving credit facilities119.6 31.4 
Repayments on revolving credit facilities(68.2)(24.2)
Payments of dividends on common stock(15.8)(15.6)
Proceeds from stock option exercises 0.8 0.6 
Payments for employee taxes on net settlement equity awards(3.2)(5.3)
Other, net(1.5)(1.5)
Net cash provided by (used in) financing activities from continuing operations26.8 (17.1)
Cash provided by (used in) continuing operations25.0 (56.2)
Cash used in discontinued operations:
Operating cash flows— — 
Investing cash flows— — 
Total cash used in discontinued operations— — 
Effect of exchange rates on cash and cash equivalents(14.4)5.6 
Net cash flows10.6 (50.6)
Cash, cash equivalents, and restricted cash:  
At beginning of period227.9 250.2 
At end of period$238.5 $199.6 

See Condensed Notes to Consolidated Financial Statements

5
Hillenbrand, Inc.
Consolidated Statements of Shareholders’ Equity (Unaudited)
(in millions)
Three Months Ended December 31, 2024
Common StockAdditional
Paid-in
Capital		Retained
Earnings		Treasury StockAccumulated
Other
Comprehensive
Loss		Noncontrolling
Interests		Total
SharesSharesAmount
Balance at September 30, 202475.8 $712.6 $1,045.2 5.6 $(238.2)$(96.6)$34.4 $1,457.4 
Total other comprehensive loss, net of tax— — — — — (34.6)(0.6)(35.2)
Net income— — 6.4 — — — 2.5 8.9 
Issuance/retirement of stock for stock awards/options— (10.0)— (0.2)7.6 — — (2.4)
Share-based compensation— 4.7 — — — — — 4.7 
Dividends ($0.225 per share)
— 0.3 (16.1)— — — (1.2)(17.0)
Balance at December 31, 202475.8 $707.6 $1,035.5 5.4 $(230.6)$(131.2)$35.1 $1,416.4 

Three Months Ended December 31, 2023
Common StockAdditional
Paid-in
Capital		Retained
Earnings		Treasury StockAccumulated
Other
Comprehensive
Loss		Noncontrolling
Interests		Total
SharesSharesAmount
Balance at September 30, 202375.8 $709.5 $1,319.6 5.9 $(251.7)$(147.1)$32.6 $1,662.9 
Total other comprehensive income, net of tax— — — — — 56.2 — 56.2 
Net income— — 17.2 — — — 2.0 19.2 
Issuance/retirement of stock for stock awards/options— (13.7)— (0.2)9.0 — — (4.7)
Share-based compensation— 5.2 — — — — — 5.2 
Dividends ($0.2225 per share)
— 0.2 (15.8)— — — (1.2)(16.8)
Purchase of noncontrolling interests— — — — — — (3.0)(3.0)
Balance at December 31, 202375.8 $701.2 $1,321.0 5.7 $(242.7)$(90.9)$30.4 $1,719.0 


See Condensed Notes to Consolidated Financial Statements

6
Hillenbrand, Inc.
Condensed Notes to Consolidated Financial Statements (Unaudited)
(in millions, except share and per share data)
 
1.Background and Basis of Presentation
 
Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for TomorrowTM, we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.

On February 1, 2023, the Company completed the divestiture of its historical Batesville reportable operating segment (“Batesville”) to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $761.5, including an $11.5 subordinated note.

This divestiture represented a strategic shift in Hillenbrand’s business and qualified as a discontinued operation. Accordingly, the operating results and cash flows related to Batesville have been reflected as discontinued operations in the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for all periods presented. Unless otherwise noted, discussion within the condensed notes to the Consolidated Financial Statements relates to continuing operations only and excludes Batesville.

Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. Advanced Process Solutions is a leading global provider of highly-engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions is a global leader in highly-engineered equipment, systems, and aftermarket parts and service for the plastic technology processing industry. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, hot runner systems, process control systems, mold bases and components, and maintenance, repair, and operating (“MRO”) supplies.
 
The Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include three subsidiaries where the Company’s ownership percentage is less than 100%.  The Company’s fiscal year ends on September 30.  Unless otherwise stated, references to years refer to fiscal years.
 
These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2024, as filed with the SEC on November 19, 2024. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the consolidated results of operations to be expected for the full fiscal year.
 
The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period.  Actual results could differ from those estimates.  Examples of such estimates include, but are not limited to, revenue recognition under the over time method, establishment of reserves related to credit losses, warranties, income taxes, litigation, and self-insurance.


2.Summary of Significant Accounting Policies
 
The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2024.

7
Recently issued accounting standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025), and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements.
 
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements.

In March 2024, the SEC adopted final rules requiring public entities to provide certain climate-related information in their registration statements and annual reports. As part of the disclosures, entities will be required to quantify certain effects of severe weather events and other natural conditions in a note to their audited financial statements. The rules will be effective for annual periods beginning in calendar 2025 (fiscal 2026). In April 2024, the SEC voluntarily stayed implementation of the final rules pending certain legal challenges. The Company is assessing the effect of the new rules on our Consolidated Financial Statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires, among other items, additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the Consolidated Statement of Operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 (fiscal 2028), and for interim periods within fiscal years beginning after December 15, 2027 (fiscal 2029), with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on the Consolidated Financial Statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

3.Revenue Recognition

Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers.

Contract balances

The balance in receivables from long-term manufacturing contracts at December 31, 2024 and September 30, 2024, was $289.5 and $302.7, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2024 and September 30, 2024, was $293.8 and $315.2, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the three months ended December 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2024 and 2023, was $95.6 and $116.4, respectively. During the three months ended December 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Transaction price allocated to the remaining performance obligations
                                            
As of December 31, 2024, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Quarterly Report on Form 10-Q, was $1,816.7. Approximately 88% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years.

8
Disaggregation of revenue

The following tables present net revenue by geography:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Geography (1)
Americas$229.2 $102.9 $332.1 $264.2 $109.9 $374.1 
Asia128.8 60.2 189.0 146.3 60.5 206.8 
Europe, the Middle East, and Africa153.1 32.7 185.8 157.8 34.6 192.4 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 
(1)The Company attributes net revenue to a geography based upon the location of the end customer.

The following tables present net revenue by timing of transfer:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Timing of transfer
Point in time$269.8 $181.1 $450.9 $278.2 $186.4 $464.6 
Over time241.3 14.7 256.0 290.1 18.6 308.7 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 

9
4.Supplemental Consolidated Balance Sheet Information

December 31, 2024September 30, 2024
Allowance for credit losses$13.7 $13.6 
Warranty reserves$46.7 $47.9 
Accumulated depreciation on property, plant, and equipment$268.7 $265.6 
Inventories, net:  
Raw materials and components$248.1 $247.0 
Work in process120.1 127.6 
Finished goods153.5 150.6 
Total inventories, net$521.7 $525.2 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:
December 31, 2024December 31, 2023
Cash and cash equivalents$208.0 $198.4 
Short-term restricted cash included in other current assets6.9 1.2 
Long-term restricted cash included in other long-term assets23.6 — 
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows$238.5 $199.6 

Equity Method Investment

The Consolidated Financial Statements include our 46% interest in TerraSource Holdings, LLC (“Holdings”), which is accounted for using the equity method of accounting as we have significant influence over the operating and financial policies of Holdings; however, we do not control Holdings. When we record our proportionate share of net income, we record it as a reduction to Operating expenses in the Consolidated Statements of Operations and increase the carrying value of our equity method investment. Conversely, when we record our proportionate share of a net loss, if applicable, we record it within Operating expenses in the Consolidated Statements of Operations and decrease the carrying value of our equity method investment. The value of our equity method investment in Holdings, which is recorded in Other long-term assets, was $12.0 and $9.2 at December 31, 2024 and September 30, 2024, respectively. We recorded our proportionate share of net income of Holdings of $2.8 and $1.5 for the three months ended December 31, 2024 and 2023, respectively, as a reduction of Operating expenses.

Supplier Finance Program

The Company has an agreement with a third-party to facilitate a supply chain finance (“SCF”) program with participating financial institutions. The SCF program allows qualifying suppliers to sell their receivables, on an invoice level at the selection of the supplier, from the Company to the financial institutions and negotiate their outstanding receivable arrangements and associated fees directly with the financial institutions. Hillenbrand is not party to the agreements between the supplier and the financial institutions. The supplier invoices that have been confirmed as valid under the SCF program require payment in full by the financial institutions to the supplier by the original maturity date of the invoice, or discounted payment at an earlier date as agreed upon with the supplier. The Company’s obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by a supplier’s participation in the SCF program.
 
10
All outstanding amounts related to suppliers participating in the SCF program are recorded upon confirmation with the third-party financial institutions in trade accounts payable in the Consolidated Balance Sheets, and associated payments are included in cash used in operating activities in the Consolidated Statements of Cash Flows. The Company’s outstanding obligations included in trade accounts payable as of December 31, 2024 and September 30, 2024, were $14.4 and $16.0, respectively.

Trade Receivables Financing Agreements

The Company sells a small percentage of its trade receivables to outside financial institutions in the normal course of business. These trade receivable financing agreements are accounted for as a true sale of assets under the provisions of Accounting Standards Codification (“ASC”) 860, Transfer and Servicing (“ASC 860”). During fiscal 2024, the Company executed an amendment of one of its trade receivables financing agreement (as amended, the “Amended Agreement”) with a financial institution. In accordance with ASC 860 this Amended Agreement is deemed a true sale, as the Company retains no rights or interest and has no obligations with respect to the trade receivables, and has no continuing involvement with the trade receivables once transferred to the financial institution. As part of the Amended Agreement, we receive the majority of the proceeds of the trade receivables sold to the financial institution upon sale in cash (level 1 fair value measurement) with the remaining portion of the proceeds held by the financial institution as a deferred purchase price (“DPP”) (level 2 fair value measurement) until the collection of the trade receivables sold. The DPP receivables are ultimately realized by the Company following the collection of the underlying trade receivables sold to the financial institution (typically within 90 - 120 days). As defined in the Amended Agreement, the financial institution is responsible for any credit risk associated with the sold trade receivables. There is no limit on the amount of trade receivables that can be sold under the Amended Agreement; however, all trade receivables must be accepted by the financial institution prior to sale.

Sales of trade receivables under the Amended Agreement and other trade receivable factoring arrangements were $70.8 and $7.2 for the three months ended December 31, 2024 and 2023, respectively, and cash collections from customers on trade receivables sold were $71.7 and $7.2 during the three months ended December 31, 2024 and 2023, respectively. The Company acts as a servicer (collects customer cash on behalf of the financial institution) for one of its trade receivables factoring arrangements. The servicing fee associated with this trade receivables factoring arrangement was not material to the Company for the three months ended December 31, 2024 and 2023, respectively. Amounts collected on behalf of the financial institution under this trade receivables factoring arrangement and owed to the financial institution were $2.2 and $3.1 at December 31, 2024 and September 30, 2024, respectively. The loss on the sale of trade receivables under the Amended Agreement and other trade receivables factoring arrangements was not material to the Company for the three months ended December 31, 2024 and 2023. As of December 31, 2024 and September 30, 2024, trade receivables in the amount of $28.5 and $34.2, respectively were sold to the financial institution and are not reflected in trade receivables in the Consolidated Balance Sheets.

The following roll forward summarizes the activity related to the DPP receivables:

Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Beginning DPP receivables balance$6.7 $— 
Non-cash additions to DPP receivables9.2 — 
Cash collections on DPP receivables(10.1)— 
Ending DPP receivables balance$5.8 $— 


5.Leases

For the three months ended December 31, 2024 and 2023, the Company recognized $10.5 and $8.5 of operating lease expense, respectively, including short-term lease expense and variable lease costs, which were immaterial in each period. The Company’s finance leases were insignificant as of December 31, 2024 and September 30, 2024.

The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases:
11
December 31, 2024September 30, 2024
Operating lease right-of-use assets, net$157.8$168.7
Other current liabilities20.522.0
Operating lease liabilities131.8141.1
Total operating lease liabilities$152.3$163.1
Weighted-average remaining lease term (in years)10.110.3
Weighted-average discount rate6.3 %6.3 %

As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows:
2025 (excluding the three months ended December 31, 2024)
$21.4 
202625.9 
202723.0 
202820.8 
202919.2 
Thereafter111.4 
Total lease payments221.7 
Less: imputed interest(69.4)
Total present value of lease payments$152.3 

Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows:
Three Months Ended December 31,
20242023
Cash paid for amounts included in the measurement of operating lease liabilities$8.0 $6.8 
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities4.6 4.9 
Operating leases acquired in business combinations— 3.5 

6.Intangible Assets and Goodwill

Intangible Assets

Intangible assets are stated at the lower of cost or fair value. Intangible assets are amortized on a straight-line basis over periods ranging from three to 21 years, representing the period over which the Company expects to receive future economic benefits from these assets. The Company assesses the carrying value of indefinite-lived trade names annually, or more often if events or changes in circumstances indicate there may be an impairment.

12
The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of:

 December 31, 2024September 30, 2024
 CostAccumulated
Amortization		CostAccumulated
Amortization
Finite-lived assets:    
Customer relationships$1,278.6 $(386.8)$1,316.9 $(379.4)
Technology, including patents189.3 (101.8)192.3 (100.9)
Software56.4 (38.9)53.0 (35.3)
Trade names50.2 (11.5)52.5 (10.6)
 1,574.5 (539.0)1,614.7 (526.2)
Indefinite-lived assets:    
Trade names193.9 — 197.4 — 
Total$1,768.4 $(539.0)$1,812.1 $(526.2)

Finite-lived intangible assets, net of $658.6 and $693.0 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $108.8 and $112.3 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. The net change in intangible assets in the Advanced Process Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments.

Finite-lived intangible assets, net of $369.7 and $388.3 are included in the Molding Technology Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $85.1 are included in the Molding Technology Solutions reportable operating segment at both December 31, 2024 and September 30, 2024. The net change in intangible assets in the Molding Technology Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments.

Goodwill

Goodwill is not amortized, but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment.  Impairment testing is performed at a reporting unit level.

The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2024:
 Advanced Process SolutionsMolding Technology SolutionsTotal
Balance as of September 30, 2024$1,430.2 $405.5 $1,835.7 
Foreign currency adjustments(48.7)(7.9)(56.6)
Balance as of December 31, 2024
$1,381.5 $397.6 $1,779.1 

During the three months ended December 31, 2024 and 2023, the Company did not observe any triggering events or substantive changes in circumstances requiring the need for an interim impairment assessment.

13
7.Financing Agreements
The following table summarizes Hillenbrand’s current and long-term debt as of:
December 31, 2024September 30, 2024
$1,000 revolving credit facility (excluding outstanding letters of credit)
$329.0 $298.5 
$200 term loan
180.0 182.5 
€185 term loan
180.9 196.5 
$500 senior unsecured notes (1)
495.0 494.6 
$375 senior unsecured notes (2)
373.8 373.6 
$350 senior unsecured notes (3)
347.2 347.1 
Other— 0.2 
Total debt1,905.9 1,893.0 
Less: current portion 20.9 20.6 
Total long-term debt$1,885.0 $1,872.4 
(1)Includes unamortized debt issuance costs of $5.0 and $5.4 at December 31, 2024 and September 30, 2024, respectively.
(2)Includes unamortized debt issuance costs of $1.0 and $1.2 at December 31, 2024 and September 30, 2024, respectively.
(3)Includes unamortized debt issuance costs of $2.8 and $2.9 at December 31, 2024 and September 30, 2024, respectively.

As of December 31, 2024, the Company had $17.7 in outstanding letters of credit issued and $653.3 of borrowing capacity under the revolving credit facility (the “Facility”), of which $424.3 was immediately available based on the Company’s most restrictive covenant. The weighted-average interest rate on borrowings under the Facility was 4.96% and 5.84% for the three months ended December 31, 2024 and 2023, respectively. The weighted average facility fee on the Facility was 0.24% and 0.20% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the $200 term loan was 6.69% and 5.60% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the €185 term loan was 5.05% and 5.60% for the three months ended December 31, 2024 and 2023, respectively.

Remaining unamortized deferred financing costs related to the Facility, $200 term loan and €185 term loan were $5.0 in aggregate, as of December 31, 2024, and are being amortized to interest expense over the remaining term of these agreements.

In the normal course of business, the Company provides, primarily to certain customers, bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of December 31, 2024 and September 30, 2024, the Company had credit arrangements totaling $561.3 and $594.3, respectively, under which $331.7 and $400.2, respectively, were used for guarantees. These arrangements include the Company’s Syndicated L/G Facility Agreement (“L/G Facility”) and other ancillary credit facilities. Remaining unamortized deferred financing costs related to the L/G Facility were $1.4 as of December 31, 2024, and are being amortized to interest expense over the remaining term of the agreement.

As of December 31, 2024, Hillenbrand was in compliance with all covenants contained in the foregoing agreements and credit instruments and there were no events of default.

14
8.Retirement Benefits
 
Defined Benefit Plans

Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows:
 
U.S. Pension BenefitsNon-U.S. Pension Benefits
Three Months Ended December 31,Three Months Ended December 31,
 2024202320242023
Service costs$— $— $0.7 $0.5 
Interest costs0.2 2.0 0.8 1.1 
Expected return on plan assets— (2.7)(0.3)(0.4)
Amortization of net loss (gain)— 0.1 (0.2)(0.2)
Settlement (gain) charge(1.7)8.3 — — 
Net periodic pension (benefit) cost$(1.5)$7.7 $1.0 $1.0 

On July 18, 2023, we announced an offer to provide former employees who are participants in the Company’s U.S. defined benefit pension plan (the “Plan”) the opportunity to elect a lump sum distribution of their earned Plan benefits. The Plan’s fiduciaries made lump sum payments to electing eligible participants in December 2023, funded by the existing assets in the Plan. In April 2024, the remaining assets of the Plan were used to purchase annuities to support the remaining obligation, resulting in the termination and liquidation of the Plan. During the three months ended December 31, 2024, the Company received one-time premium refunds of $1.7 related to the termination of the Plan, which was recorded as a pretax pension settlement gain on the Consolidated Statement of Operations. During the three months ended December 31, 2023, the Company recorded a non-cash settlement pre-tax charge of $8.3, related to the termination and liquidation of the Plan.

Defined Contribution Plans

Expenses related to the Company’s defined contribution plans were $3.1 and $2.9 for the three months ended December 31, 2024, and 2023, respectively.

9.Income Taxes
 
The effective tax rates for the three months ended December 31, 2024 and 2023 were 41.8% and 33.9%, respectively. The increase in the effective tax rate was primarily driven by an increase in unrecognized tax benefits, the expiration of a reduced incentive tax rate for certain operations located in China, and a reduced discrete tax benefit for equity compensation, partially offset by the revaluation of Canadian deferred tax liabilities as a result of currency fluctuation, and a reduction of the tax accrual for unrepatriated earnings.


15
10.Earnings per share

The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective Consolidated Balance Sheet date.  Potential dilutive effects, representing approximately 630,000 and 440,000 shares at December 31, 2024 and 2023, respectively, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.
Three Months Ended
December 31,
 20242023
Income from continuing operations$8.9 $19.5 
Less: Net income attributable to noncontrolling interests2.5 2.0 
Income from continuing operations attributable to Hillenbrand$6.4 $17.5 
Weighted-average shares outstanding (basic - in millions)70.6 70.3 
Effect of dilutive stock options and other unvested equity awards (in millions)— 0.2 
Weighted-average shares outstanding (diluted - in millions)70.6 70.5 
Basic earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Diluted earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)0.9 0.6 
 

11. Accumulated Other Comprehensive Loss

The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss:
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2024$(15.6)$(55.4)$(25.6)$(96.6)  
Other comprehensive loss before reclassifications:      
Before tax amount1.1 (63.3)26.5 (35.7)$(0.6)$(36.3)
Tax benefit (0.3)— 0.7 0.4 — 0.4 
After tax amount0.8 (63.3)27.2 (35.3)(0.6)(35.9)
Amounts reclassified from accumulated other comprehensive loss (2)
— — 0.7 0.7 — 0.7 
Net current period other comprehensive income (loss)0.8 (63.3)27.9 (34.6)$(0.6)$(35.2)
Balance at December 31, 2024$(14.8)$(118.7)$2.3 $(131.2)  
(1)Includes gain and losses on intra-entity foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.

16
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2023$(34.5)$(107.1)$(5.5)$(147.1)  
Other comprehensive income before reclassifications:      
Before tax amount(0.4)49.3 0.3 49.2 $— $49.2 
Tax benefit0.2 — (0.1)0.1 — 0.1 
After tax amount(0.2)49.3 0.2 49.3 — 49.3 
Amounts reclassified from accumulated other comprehensive loss (2)
6.2 — 0.7 6.9 — 6.9 
Net current period other comprehensive income 6.0 49.3 0.9 56.2 $— $56.2 
Balance at December 31, 2023$(28.5)$(57.8)$(4.6)$(90.9)  
(1)Includes gains and losses on intra-foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.

Reclassifications out of accumulated other comprehensive loss include: 
 Three Months Ended December 31, 2024
 
Amortization of Pension and
Postretirement (1)
Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $0.3 $0.3 
Operating expenses— — 0.5 0.5 
Total before tax$— $— $0.8 $0.8 
Tax expense(0.1)
Total reclassifications for the period, net of tax$0.7 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

 Three Months Ended December 31, 2023
 
Amortization of Pension and
Postretirement (1)
(Gain) Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $(0.1)$(0.1)
Cost of goods sold— — 0.3 0.3 
Operating expenses8.2 — 0.5 8.7 
Total before tax$8.2 $— $0.7 $8.9 
Tax expense(2.0)
Total reclassifications for the period, net of tax$6.9 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

17
12.Share-Based Compensation
Three Months Ended
December 31,
 20242023
Share-based compensation costs $4.7 $5.2 
Less impact of income taxes1.1 1.2 
Share-based compensation costs, net of tax$3.6 $4.0 
 
The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value, as well as time-based awards. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated stock index. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period.  For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants. 
 
During the three months ended December 31, 2024, the Company made the following grants:
 
 Number of
Units
Time-based stock awards354,713 
Performance-based stock awards (maximum that can be earned)588,686 
 
The Company’s time-based stock awards and performance-based stock awards granted during the three months ended December 31, 2024, had weighted-average grant date fair values of $33.62 and $40.06, respectively. Included in the performance-based stock awards granted during the three months ended December 31, 2024 are 294,386 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above.  These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.
 
13.Commitments and Contingencies
 
From time to time, Hillenbrand is involved in claims, lawsuits, and government proceedings relating to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment-related, and other matters.  The ultimate outcome of any claims, lawsuits, and proceedings cannot be predicted with certainty.  An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters.  If a loss is not considered probable or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred.  Legal fees associated with claims and lawsuits are generally expensed as incurred.
 
Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period.  For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary often provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses.  For all other types of claims, reserves are established when payment is considered probable and are based upon advice from internal and external counsel and historical settlement information for such claims.
 
The recorded amounts represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.

At December 31, 2024 and September 30, 2024, the Company had $11.2, included in other current liabilities on the Consolidated Balance Sheets, related to a discrete commercial dispute stemming from a contract entered into with a Molding Technology Solutions’ customer prior to the Company’s acquisition of the Molding Technology Solutions reportable operating segment.
18

14.Fair Value Measurements
 
Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date.  The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available.  Observable inputs are from sources independent of the Company.  Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances.  The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The hierarchy is broken down into three levels:
 
Level 1:Inputs are quoted prices in active markets for identical assets or liabilities.
Level 2:Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly.
Level 3:Inputs are unobservable for the asset or liability.
 
See the section below titled “Valuation techniques” for further discussion of how Hillenbrand determines fair value for certain assets and liabilities.
Carrying Value at December 31, 2024
Fair Value at December 31, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$208.0 $208.0 $— $— 
DPP receivables5.8 — 5.8 — 
Restricted cash1.0 1.0 — — 
Restricted cash for benefit plan contributions29.5 29.5 — — 
Investments in rabbi trust5.5 5.5 — — 
Derivative instruments22.3 — 22.3 — 
Liabilities:
Revolving credit facility329.0 — 329.0 — 
$200 term loan
180.0 — 180.0 — 
€185 term loan
180.9 — 180.9 — 
$350 senior unsecured notes
350.0 306.2 — — 
$375 senior unsecured notes
374.8 372.1 — — 
$500 senior unsecured notes
500.0 501.4 — — 
Derivative instruments28.1 — 28.1 — 
Contingent consideration14.6 — — 14.6 
 
19
 
Carrying Value at September 30, 2024
Fair Value at September 30, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$199.3 $199.3 $— $— 
DPP receivables6.7 — 6.7 — 
Restricted cash1.1 1.1 — — 
Restricted cash for benefit plan contributions27.5 27.5 — — 
Investments in rabbi trust4.8 4.8 — — 
Derivative instruments19.0 — 19.0 — 
Liabilities:    
Revolving credit facility298.5 — 298.5 — 
$200 term loan
182.5 — 182.5 — 
€185 term loan
196.5 — 196.5 — 
$350 senior unsecured notes
350.0 312.9 — — 
$375 senior unsecured notes
374.8 373.7 — — 
$500 senior unsecured notes
500.0 509.8 — — 
Derivative instruments40.5 — 40.5 — 
Contingent consideration14.6 — — 14.6 

Valuation techniques
 
•Cash and cash equivalents, restricted cash, restricted cash for benefit plan contributions, and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments.
•The DPP receivables fair value is based on a discounted cash flow analysis (estimated amount expected to be received) using historical experience and inputs from similar programs, which include the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the inputs in isolation would not result in a materially different fair value estimate. Based on the short-term nature of the DPP receivables, typically 90 -120 days, they are classified as a level 2 measurement.
•The Company estimates the fair value of foreign currency derivatives using industry accepted models.  The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility.  These inputs were obtained from pricing services, broker quotes, and other sources.
•The fair values of the amounts outstanding under the Facility, $200 term loan, and €185 term loan approximate carrying value, as the Company believes their variable interest rate terms correspond to current market terms, and therefore, are classified within Level 2 of the fair value hierarchy.
•The fair values of the $350 senior unsecured notes, $375 senior unsecured notes, and $500 senior unsecured notes were based on quoted prices in active markets and are classified within Level 1 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.
•The contingent consideration of $14.6 reflects the estimated fair value of contingent future cash payments to the previous owners of FPM for research and development tax credits that were generated by FPM prior to the acquisition date. The Company estimated the fair value of the contingent consideration based on the technical merits of the research and development tax credits using an internally developed analysis. The key inputs to this calculation include the nature of the research and development activities, personnel involved in the research and development activities, the level of research and development spend prior to acquisition by the Company, and interpretation of applicable tax law. The value of these credits is subject to audit by the tax authorities and to the closing of the statute of limitations for the year in which the tax credits are fully utilized, the timing of which is not able to be determined at this time, but we expect to extend several years. There have been no changes in the estimated fair value of the initial calculation of the contingent consideration during the three months ended December 31, 2024. The inputs for the liability are unobservable, and therefore, are classified within Level 3 of the fair value hierarchy.
20

Derivative instruments

Hillenbrand participates in cross-currency swap agreements aiming to hedge the variability in the movement of foreign currency exchange rates for its operations in Europe, while simultaneously lowering the Company’s overall borrowing costs. The maturity dates of these agreements range from 2027 to 2029. These agreements qualify for hedge accounting and accordingly the changes in the fair value of the derivatives are recorded in other comprehensive (loss) income and remain in accumulated other comprehensive loss attributable to Hillenbrand in shareholders’ equity until the hedged item is recognized in earnings. We assess the effectiveness of cross-currency swap contracts using the spot method, and the difference between the interest rate received and paid under the cross-currency swap agreements is recorded in interest expense, net, in the Consolidated Statements of Operations. As a result of participating in these cross-currency swap agreements, Hillenbrand recorded a reduction in interest expense, net of $3.2 and $0.0 during the three months ended December 31, 2024 and 2023, respectively. Hillenbrand presents the cross-currency swap agreements’ periodic settlements in operating activities in the Consolidated Statements of Cash Flows.

The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months.

The aggregate notional value of the cross-currency swap agreements was $691.9 and $727.8 at December 31, 2024 and September 30, 2024, respectively. The aggregate notional value of the foreign currency exchange forward contract derivatives was $262.4 and $172.5 at December 31, 2024 and September 30, 2024, respectively. The derivatives are recorded at fair value in prepaid expenses and other current assets, other current liabilities, and other long-term liabilities in the Consolidated Balance Sheets.

15.Segment and Geographical Information

As previously described, on February 1, 2023, the Company completed the divestiture of Batesville. The operating results and cash flows for Batesville have been classified as discontinued operations within the Consolidated Financial Statements for all periods presented.

Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. The Company’s reportable operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance.

The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs.  Corporate provides management and administrative services to each reportable operating segment.  These services include treasury management, human resources, legal, business development, information technology, tax compliance, global supply management, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting.  With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments.

21
The following tables present financial information for the Company’s reportable operating segments and significant geographical locations:
 Three Months Ended December 31,
 20242023
Net revenue
Advanced Process Solutions$511.1 $568.3 
Molding Technology Solutions195.8 205.0 
Total$706.9 $773.3 
Adjusted EBITDA (1)
Advanced Process Solutions$82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Net revenue (2)
United States$284.7 $326.9 
China81.1 91.9 
India57.1 57.9 
Germany51.1 59.1 
All other countries232.9 237.5 
Total$706.9 $773.3 
 
(1)Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP financial measure used by management to measure segment performance and make operating decisions.
(2)The Company attributes net revenue to a geography based upon the location of the end customer.

 December 31, 2024September 30, 2024
Total assets  
Advanced Process Solutions$3,331.7 $3,470.8 
Molding Technology Solutions1,551.2 1,600.0 
Corporate176.5 167.9 
Total$5,059.4 $5,238.7 
Tangible long-lived assets, net  
United States$184.1 $186.1 
Germany123.5 134.5 
China 34.8 37.1 
India33.9 35.6 
All other foreign business units85.2 92.0 
Total$461.5 $485.3 
22

The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income:
 Three Months Ended
December 31,
20242023
Adjusted EBITDA:
Advanced Process Solutions $82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Add:
Loss from discontinued operations (net of income tax expense)— (0.3)
Less:
Interest expense, net25.1 29.8 
Income tax expense6.4 10.0 
Depreciation and amortization37.9 38.8 
Pension settlement (gain) charge(1.7)8.3 
Business acquisition, divestiture, and integration costs18.1 5.6 
Inventory step-up costs— 1.5 
Restructuring and restructuring-related charges 2.4 0.6 
Consolidated net income$8.9 $19.2 
 


16.Subsequent Event

On February 5, 2025, the Company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection molding and extrusion business to an affiliate of Bain Capital, while retaining an approximate 49% ownership stake. The purchase price is expected to be $287.0, subject to customary adjustments, and will be paid in cash. The Company expects the transaction to close in the second or third quarter of 2025.
23
Item 2.        MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
(financial amounts in millions, except share and per share data, throughout Management’s Discussion and Analysis)

FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS
 
Throughout this Quarterly Report on Form 10-Q, we make a number of “forward-looking statements,” including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these sections. These are statements about future sales, earnings, cash flow, results of operations, uses of cash, financings, share repurchases, ability to meet deleveraging goals, and other measures of financial performance or potential future plans or events, strategies, objectives, beliefs, prospects, assumptions, expectations, and projected costs or savings or transactions of the Company that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand’s expectations and projections.

The following list, though not exhaustive, contains words that could indicate a forward-looking statement.

 
intendbelieveplanexpectmaygoalwouldprojectpositionfutureoutlook
becomepursueestimatewillforecastcontinuecouldanticipateremainlikely
targetencouragepromiseimproveprogresspotentialshouldimpactstrategyassume
 
Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: global market and economic conditions, including those related to the continued volatility in the financial markets, including as a result of the United States (“U.S.”) presidential election; the risk of business disruptions associated with information technology, cyber-attacks, or catastrophic losses affecting infrastructure; increasing competition for highly skilled and talented workers, as well as labor shortages; closures or slowdowns and changes in labor costs and labor difficulties; uncertainty related to environmental regulation and industry standards, as well as physical risks of climate change; uncertainty related to environmental regulation, including the Securities and Exchange Commission’s (“SEC”) final climate rules and litigation regarding its enforceability; increased costs, poor quality, or unavailability of raw materials or certain outsourced services and supply chain disruptions; economic and financial conditions including volatility in interest and exchange rates, commodity and equity prices and the value of financial assets; uncertainty in U.S. global trade policy and risks with governmental instability in certain parts of the world such as Germany; our level of international sales and operations; negative effects of acquisitions, including the Schenck Process Food and Performance Materials (“FPM”) business and Linxis Group SAS (“Linxis”) acquisitions, on the Company’s business, financial condition, results of operations and financial performance; competition in the industries in which we operate, including on price; cyclical demand for industrial capital goods; the ability to recognize the benefits of any acquisition or divestiture, including the Milacron injection molding and extrusion business sale (the “Proposed Transaction”), including potential synergies and cost savings or the failure of the Company or any acquired company, or the Proposed Transaction, to achieve its plans and objectives generally; any failure by the parties to satisfy any conditions to the Proposed Transaction; the possibility that the Proposed Transaction is ultimately not consummated; potential adverse effects of the announcement or results of the Proposed Transaction on the market price of the Company’s common stock or on the ability of the Company to develop and maintain relationships with its personnel and customers, suppliers and others with whom it does business or otherwise on the Company’s business, financial condition, results of operations and financial performance; risks related to diversion of management’s attention from our ongoing business operations due to the Proposed Transaction; impacts of decreases in demand or changes in technological advances, laws, or regulation on the net revenues that we derive from the plastics industry; the impact to the Company’s effective tax rate of changes in the mix of earnings or in tax laws and certain other tax-related matters; exposure to tax uncertainties and audits; involvement in claims, lawsuits, and governmental proceedings related to operations; uncertainty in the U.S. political and regulatory environment, including as a result of the U.S. presidential election and any proposed tariffs; adverse foreign currency fluctuations; and labor disruptions. There can be no assurances that the Proposed Transaction will be consummated.

Shareholders, potential investors, and other readers are urged to consider these risks and uncertainties in evaluating forward-looking statements and are cautioned not to place undue reliance on the forward-looking statements. For a more in-depth discussion of certain factors that could cause actual results to differ from those contained in forward-looking statements, see the discussion under the heading “Risk Factors” in Part I, Item 1A of Hillenbrand’s Form 10-K for the year ended September 30,
24
2024, filed with the SEC on November 19, 2024, as well as other risks and uncertainties detailed in our other filings with the SEC from time to time. Any forward-looking statement made in this Quarterly Report on Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update or revise any forward-looking statement, whether written or oral, made to reflect new information, future developments or otherwise.
 
EXECUTIVE OVERVIEW
 
Hillenbrand (www.Hillenbrand.com) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for TomorrowTM, we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.

OPERATING PERFORMANCE MEASURES
 
The following discussion compares our results for the three months ended December 31, 2024, to the same period in 2023.  The Company’s fiscal year ends on September 30.  Unless otherwise stated, references to years refer to fiscal years.  We begin the discussion at a consolidated level and then provide separate detail about Advanced Process Solutions, Molding Technology Solutions, and Corporate.  These results of operations are prepared in accordance with GAAP.
 
We also provide certain non-GAAP operating performance measures. These non-GAAP financial measures are referred to as “adjusted” measures and generally exclude expenses associated with business acquisition, divestiture, and integration costs, restructuring and restructuring-related charges, pension settlement (gain) charge, and inventory step-up costs.

Non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

We use this non-GAAP information internally to measure operating segment performance and make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of our ongoing operating results.  The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by items such as the above excluded items.  We believe this information provides a higher degree of transparency.
 
An important non-GAAP financial measure that we use is adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”). A part of Hillenbrand’s strategy is to selectively acquire companies that we believe can benefit from the Hillenbrand Operating Model (“HOM”) to spur faster and more profitable growth. Given that strategy, it is a natural consequence to incur related expenses, such as amortization from acquired intangible assets and additional interest expense from debt-funded acquisitions. Accordingly, we use adjusted EBITDA, among other measures, to monitor our business performance. Adjusted EBITDA is not a recognized term under GAAP and therefore does not purport to be an alternative to net income. Further, the Company’s measure of adjusted EBITDA may not be comparable to similarly titled measures of other companies.
 
Another important operational measure used is backlog. Backlog is not a term recognized under GAAP; however, it is a common measurement used in industries with extended lead times for order fulfillment (long-term contracts), like those in which our reportable operating segments compete. Backlog represents the amount of net revenue that we expect to realize on contracts awarded to our reportable operating segments. For purposes of calculating backlog, 100% of estimated net revenue attributable to consolidated subsidiaries is included. Backlog includes expected net revenue from large systems and equipment, as well as aftermarket parts, components, and service. The length of time that projects remain in backlog can span from days for aftermarket parts or service to approximately 18 to 24 months for larger system sales within the Advanced Process Solutions reportable operating segment. The majority of the backlog within the Molding Technology Solutions reportable operating segment is expected to be fulfilled within the next twelve months. Backlog includes expected net revenue from the remaining portion of firm orders not yet completed, as well as net revenue from change orders to the extent that they are reasonably expected to be realized. We include in backlog the full contract award, including awards subject to further customer approvals, which we expect to result in net revenue in future periods. In accordance with industry practice, our contracts may include provisions for cancellation, termination, or suspension at the discretion of the customer.

25
We expect that future net revenue associated with our reportable operating segments will be influenced by order backlog because of the lead time involved in fulfilling engineered-to-order equipment for customers. Although backlog can be an indicator of future net revenue, it does not include projects and parts orders that are booked and shipped within the same quarter. The timing of order placement, size, extent of customization, and customer delivery dates can create fluctuations in backlog and net revenue. Net revenue attributable to backlog may also be affected by foreign exchange fluctuations for orders denominated in currencies other than U.S. dollars.

We calculate the foreign currency impact on net revenue, gross profit, operating expenses, backlog, consolidated net income, and adjusted EBITDA in order to better measure the comparability of results between periods. We calculate the foreign currency impact by translating current year results at prior year foreign exchange rates. This information is provided because exchange rates can distort the underlying change in these metrics, either positively or negatively. The cost structure for Corporate is generally not significantly impacted by the fluctuation in foreign exchange rates, and we do not disclose the foreign currency impact in the Operations Review section below where the impact is not significant.
 
See page 29 for a reconciliation of adjusted EBITDA to consolidated net income, the most directly comparable GAAP financial measure. We use other non-GAAP financial measures in certain other instances and include information reconciling such non-GAAP measures to the respective most directly comparable GAAP financial measures. Given that backlog is an operational measure and that the Company’s methodology for calculating backlog does not meet the definition of a non-GAAP financial measure, as that term is defined by the SEC, a quantitative reconciliation is not required or provided.
 
CRITICAL ACCOUNTING ESTIMATES
 
For the three months ended December 31, 2024, there were no significant changes to our critical accounting estimates as outlined in our Annual Report on Form 10-K for the year ended September 30, 2024, filed with the SEC on November 19, 2024.

OPERATIONS REVIEW — CONSOLIDATED
 
 Three Months Ended December 31,
 20242023
 Amount% of Net
Revenue		Amount% of Net
Revenue
Net revenue$706.9 100.0 $773.3 100.0 
Gross profit235.0 33.2 251.0 32.5 
Operating expenses171.1 24.2 157.9 20.4 
Amortization expense25.2 25.5 
Pension settlement (gain) charge(1.7)8.3 
Interest expense, net25.1 29.8 
Income tax expense6.4 10.0 

Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023

Net revenue decreased $66.4 (9%).
 
•Advanced Process Solutions net revenue decreased $57.2 (10%), primarily driven by a decrease in volume, partially offset by favorable pricing.

•Molding Technology Solutions net revenue decreased $9.2 (5%), primarily driven by a decrease in injection molding and hot runner equipment sales. Foreign currency impact decreased net revenue by 1%.

Gross profit decreased $16.0 (6%) and gross profit margin improved 70 basis points to 33.2%. On an adjusted basis, which excludes business acquisition, divestiture, and integration costs and restructuring and restructuring-related charges, adjusted gross profit decreased $16.6 (7%), and adjusted gross profit margin improved 70 basis points to 33.4%.

26
•Advanced Process Solutions gross profit decreased $15.0 (8%), primarily driven by lower volume and cost inflation, offset by productivity improvements and favorable pricing. Gross profit margin improved 80 basis points to 34.4%, primarily driven by productivity improvements, partially offset by cost inflation.

Advanced Process Solutions gross profit included restructuring and restructuring related charges ($0.8 in 2025) and inventory step-up costs related to acquisitions ($1.5 in 2024). Excluding these non-recurring items, adjusted gross profit decreased $15.7 (8%) and adjusted gross profit margin improved 70 basis points to 34.5%.

•Molding Technology Solutions gross profit decreased $1.0 (2%) primarily driven by a decrease in volume and cost inflation, partially offset by favorable product mix and productivity improvements. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved 90 basis points to 30.3%, primarily driven by productivity improvements and favorable product mix, partially offset by cost inflation.

Operating expenses increased $13.2 (8%), primarily driven by an increase in business acquisition, divestiture, and integration costs and cost inflation. Foreign currency impact increased operating expenses by 1%. Our operating expense-to-net-revenue ratio increased by 380 basis points to 24.2%. Operating expenses included the following items:
 Three Months Ended December 31,
 20242023
Business acquisition, divestiture, and integration costs$18.1 $5.6 
Restructuring and restructuring-related charges1.4 0.5 
On an adjusted basis, which excludes business acquisition, divestiture, and integration costs and restructuring and restructuring-related charges, operating expenses were flat to prior year. Adjusted operating expenses as a percentage of net revenue increased 180 basis points to 21.4%.

Pension settlement (gain) charge decreased $10.0 due to lump-sum payments made from the Company’s U.S. pension plan to former employees who elected to receive such payments in 2024, partially offset by premium refunds received in 2025. See Note 8 of Part I, Item 1 of this Quarterly Report on Form 10-Q for further information on this pension settlement (gain) charge.

Interest expense, net decreased $4.7 (16%), primarily due to the impact of cross-currency swaps that were entered into during the quarter ended June 30, 2024.

The effective tax rate was 41.8% in 2025 compared to 33.9% in 2024. The increase in the effective tax rate was primarily driven by an increase in unrecognized tax benefits, the expiration of a reduced incentive tax rate for certain operations located in China, and a reduced discrete tax benefit for equity compensation, partially offset by the revaluation of Canadian deferred tax liabilities as a result of currency fluctuation, and a reduction of the tax accrual for unrepatriated earnings.


OPERATIONS REVIEW — Advanced Process Solutions
 
 Three Months Ended December 31,
 20242023
 Amount% of Net
Revenue		Amount% of Net
Revenue
Net revenue$511.1 100.0 $568.3 100.0 
Gross profit175.7 34.4 190.7 33.6 
Operating expenses109.0 21.3 107.1 18.8 
Amortization expense16.4 16.7 
 
Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023
 
Net revenue decreased $57.2 (10%) primarily driven by a decrease in volume, partially offset by favorable pricing.

Order backlog decreased $332.2 (17%) from $1,915.8 at December 31, 2023, to $1,583.6 at December 31, 2024. The decrease in order backlog was primarily driven by a decrease in capital equipment orders. Foreign currency impact decreased order backlog by 3%. On a sequential basis, order backlog decreased $97.8 (6%) to $1,583.6 at December 31, 2024, down from $1,681.4 at September 30, 2024, primarily due to unfavorable foreign currency impact (4%).
27

Gross profit decreased $15.0 (8%) primarily driven by lower volume and cost inflation, offset by productivity improvements and favorable pricing. Gross profit margin improved 80 basis points to 34.4%, primarily driven by productivity improvements, partially offset by cost inflation.

Advanced Process Solutions gross profit included restructuring and restructuring related charges ($0.8 in 2025) and inventory step-up costs related to acquisitions ($1.5 in 2024). Excluding these non-recurring items, adjusted gross profit decreased $15.7 (8%) and adjusted gross profit margin improved 70 basis points to 34.5%.

Operating expenses increased $1.9 (2%) primarily driven by an increase in cost inflation and variable compensation, partially offset by productivity improvements. Operating expenses as a percentage of net revenue increased 250 basis points to 21.3%.

Operating expenses included business acquisition, divestiture, and integration costs ($7.1 in 2025 and $3.5 in 2024) and restructuring and restructuring-related charges ($0.7 in 2025 and $0.4 in 2024). Excluding these items, adjusted operating expenses decreased $2.0 (2%) and adjusted operating expenses as a percentage of net revenue increased 160 basis points to 19.8%.


OPERATIONS REVIEW — Molding Technology Solutions
  
 Three Months Ended December 31,
 20242023
 Amount% of Net
Revenue		Amount% of Net
Revenue
Net revenue$195.8 100.0 $205.0 100.0 
Gross profit59.3 30.3 60.3 29.4 
Operating expenses41.4 21.1 34.2 16.7 
Amortization expense8.8 8.8 

Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023

Net revenue decreased $9.2 (5%), primarily driven by a decrease in injection molding and hot runner equipment sales. Foreign currency impact decreased net revenue by 1%.

Order backlog increased $1.5 (1%) from $231.6 at December 31, 2023, to $233.1 at December 31, 2024. On a sequential basis, order backlog increased $2.0 (1%) to $233.1 at December 31, 2024, up from $231.1 at September 30, 2024.

Gross profit decreased $1.0 (2%) primarily driven by a decrease in volume and cost inflation, partially offset by favorable product mix and productivity improvements. Foreign currency impact decreased gross profit by 1%. Gross profit margin improved 90 basis points to 30.3%, primarily driven by productivity improvements and favorable product mix, partially offset by cost inflation.

Operating expenses increased $7.2 (21%), primarily driven by an increase in business acquisition, divestiture, and integration costs and cost inflation. Operating expense as a percentage of net revenue increased 440 basis points to 21.1%.

Operating expenses included business acquisition, divestiture, and integration costs ($4.0 in 2025) and restructuring and restructuring related costs ($0.7 in 2025). Excluding these charges, adjusted operating expenses increased $2.7 (8%) and adjusted operating expenses as a percentage of net revenue increased 220 basis points to 18.8%.

28
REVIEW OF CORPORATE EXPENSES
 
 Three Months Ended December 31,
 20242023
 Amount% of Net RevenueAmount% of Net Revenue
Core operating expenses$13.7 1.9 $14.5 1.9 
Business acquisition, divestiture, and integration costs7.0 1.0 2.1 0.3 
Operating expenses$20.7 2.9 $16.6 2.2 
 
Corporate operating expenses include the cost of providing management and administrative services to each reportable operating segment.  These services include treasury management, human resources, legal, business development, information technology, tax compliance, procurement, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting. Corporate operating expenses also include costs related to business acquisition, divestiture, and integration, which we incur as a result of our strategy to grow through selective acquisitions. Core operating expenses primarily represent corporate operating expenses excluding costs related to business acquisition, divestiture, and integration costs and restructuring and restructuring-related charges.

Business acquisition, divestiture, and integration costs include legal, tax, accounting, and other advisory fees and due diligence costs associated with investigating opportunities (including acquisitions and divestitures) and integrating completed acquisitions, and accelerating synergies and cost saving initiatives across the Company. These expenses are incurred in the Advanced Process Solutions and Molding Technology Solutions reportable operating segments, and at Corporate.

Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023
 
Operating expenses increased $4.1 (25%), primarily driven by an increase in business acquisition, divestiture, and integration costs, partially offset by an increase in equity earnings from affiliates. These expenses as a percentage of net revenue were 2.9%, an increase of 70 basis points from the prior year.

Core operating expenses decreased $0.8 (6%), primarily due to an increase in equity earnings from affiliates. These expenses as a percentage of net revenue remained flat at 1.9%.

NON-GAAP OPERATING PERFORMANCE MEASURES
 
The following is a reconciliation from consolidated net income, the most directly comparable GAAP operating performance measure, to our non-GAAP adjusted EBITDA from continuing operations.
 
 Three Months Ended December 31,
 20242023
Consolidated net income$8.9 $19.2 
Interest expense, net25.1 29.8 
Income tax expense6.4 10.0 
Depreciation and amortization37.9 38.8 
Consolidated EBITDA78.3 97.8 
Loss from discontinued operations (net of income tax expense)— 0.3 
Pension settlement (gain) charge (1)
(1.7)8.3 
Business acquisition, divestiture, and integration costs (2)
18.1 5.6 
Inventory step-up costs— 1.5 
Restructuring and restructuring-related charges (3)
2.4 0.6 
Adjusted EBITDA from continuing operations$97.1 $114.1 
 
(1)The pension settlement (gain) charge during the three months ended December 31, 2024, was due to one-time premium refunds received related to the termination of the Company’s U.S. pension plan. The pension settlement (gain) charge
29
during the three months ended December 31, 2023, was due to lump-sum payments made from the Company’s U.S. pension plan to former employees who elected to receive such payments.
(2)Business acquisition, divestiture, and integration costs during the three months ended December 31, 2024 and 2023, primarily included costs associated with the integration of recent acquisitions.
(3)Restructuring and restructuring-related charges primarily included severance costs during the three months ended December 31, 2024 and 2023.

Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023

Consolidated net income decreased $10.3 (54%) for the three months ended December 31, 2024, compared to the same period in fiscal 2024. The decrease was primarily driven by lower volume, cost inflation, and an increase in business acquisition, divestiture, and integration costs, partially offset by favorable pricing and productivity improvements, and a pension settlement charge in fiscal 2024 that did not repeat.

Consolidated adjusted EBITDA from continuing operations decreased $17.0 (15%) for the three months ended December 31, 2024, compared to the same period in fiscal 2024. The decrease was primarily driven by lower volume and cost inflation, partially offset by favorable pricing and productivity improvements. Foreign currency impact decreased adjusted EBITDA by $0.5.

LIQUIDITY AND CAPITAL RESOURCES
 
In this section, we discuss our ability to access cash to meet business needs. We discuss how we see cash flow being affected for the next twelve months and how we intend to use it. We describe actual results in generating and using cash by comparing the first three months of 2025 to the same period last year. Finally, we identify other significant matters that could affect liquidity on an ongoing basis.

Ability to Access Cash

Our debt financing has historically included revolving credit facilities, term loans, and long-term notes as part of our overall financing strategy. We regularly review and adjust the mix of fixed-rate and variable-rate debt within our capital structure in order to achieve a target range based on our financing strategy.

We have taken proactive measures to maintain financial flexibility within the landscape of various uncertainties. We believe the Company ended the quarter with and continues to have sufficient liquidity to operate in the current business environment.

As of December 31, 2024, we had $653.3 of borrowing capacity under the Facility, of which $424.3 was immediately available based on our most restrictive covenant. The available borrowing capacity reflects a reduction of $17.7 for outstanding letters of credit issued under the Facility. The Company may request an increase of up to $600.0 in the total borrowing capacity under the Facility, subject to approval of the lenders.

In the normal course of business, operating companies within our reportable operating segments provide to certain customers bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, we maintain adequate capacity to provide the guarantees. As of December 31, 2024, we had guarantee arrangements totaling $561.3, under which $331.7 was used for guarantees. These arrangements include the Amended L/G Facility Agreement under which unsecured letters of credit, bank guarantees, or other surety bonds may be issued. The Company may request an increase to the total capacity under the Amended L/G Facility Agreement by an additional €100.0, subject to approval of the lenders.

We have significant operations outside the U.S. We continue to assert that the basis differences in the majority of our foreign subsidiaries continue to be permanently reinvested outside of the U.S. We have recorded tax liabilities associated with distribution taxes on expected distributions of available cash and current earnings. The Company has made, and intends to continue to make, substantial investments in our businesses in foreign jurisdictions to support the ongoing development and growth of our international operations. As of December 31, 2024, we had a transition tax liability of $6.2 pursuant to the 2017 Tax Cuts and Jobs Act (the “Tax Act”). The cash at our foreign subsidiaries, including U.S. subsidiaries participating in non-U.S. cash pooling arrangements, totaled $175.2 at December 31, 2024. We continue to actively evaluate our global capital deployment and cash needs.

30
12-month Outlook

The Company is required to pay a transition tax on unremitted earnings of its foreign subsidiaries, resulting in an estimated liability of $6.2 recorded as of December 31, 2024. The transition tax liability is expected to be paid over the next two years.

On December 2, 2021, our Board of Directors authorized a new share repurchase program of up to $300.0, which replaced the previous $200.0 share repurchase program. The repurchase program has no expiration date but may be terminated by the Board of Directors at any time. We had approximately $125.0 remaining for share repurchases under the existing authorization at December 31, 2024.

Our anticipated contribution to our defined benefit pension plans in fiscal 2025 is $11.8, of which $1.7 was made during the three months ended December 31, 2024. We will continue to monitor plan funding levels, performance of the assets within the plans, and overall economic activity, and we may make additional discretionary funding decisions based on the net impact of the above factors.

We currently expect to pay quarterly cash dividends of approximately $15.8 based on our outstanding common stock at December 31, 2024. We increased our quarterly dividend in 2025 to $0.2250 per common share from $0.2225 per common share paid in 2024.

We believe existing cash and cash equivalents, cash flows from operations, borrowings under existing arrangements, and the issuance of debt will be sufficient to fund our operating activities and cash commitments for investing and financing activities. Based on these factors, we believe our current liquidity position is sufficient and will continue to meet all of our financial commitments in the current business environment.

Cash Flows
 Three Months Ended December 31,
20242023
Cash flows (used in) provided by:  
Operating activities from continuing operations$(11.3)$(24.0)
Investing activities from continuing operations9.5 (15.1)
Financing activities from continuing operations26.8 (17.1)
Effect of exchange rates on cash and cash equivalents(14.4)5.6 
Net cash flows$10.6 $(50.6)

Operating Activities
 
Operating activities from continuing operations used $11.3 of cash during the three months ended December 31, 2024, and used $24.0 of cash during the three months ended December 31, 2023, a $12.7 increase.  The increase in operating cash flow used in continuing operations was primarily due to favorable timing of working capital requirements.

Working capital requirements for our reportable operating segments fluctuate and may continue to fluctuate in the future due primarily to the type of product and geography of customer projects in process at any point in time.  Working capital needs are lower when advance payments from customers are more heavily weighted toward the beginning of the project. Conversely, working capital needs are higher when a larger portion of the cash is to be received in later stages of manufacturing.  
 
Investing Activities
 
The $24.6 increase in net cash flows from investing activities from continuing operations during the three months ended December 31, 2024, was primarily due to the increase in collection of deferred purchase price receivables as well as proceeds from a cross currency swap settlement.

31
Financing Activities
 
Cash used in financing activities from continuing operations was largely impacted by net borrowing activity. Our general practice is to use available cash to pay down debt unless it is needed for an acquisition. The $43.9 increase in net cash flows from financing activities from continuing operations during the three months ended December 31, 2024, was primarily due to the net borrowings on the Facility of $51.4.

We returned $15.8 to shareholders during the three months ended December 31, 2024 in the form of quarterly dividends.  We increased our quarterly dividend in fiscal 2024 to $0.2250 per common share from $0.2225 per common share paid during fiscal 2023.

Summarized Financial Information for Guarantors and the Issuer of Guaranteed Securities

Summarized financial information of Hillenbrand (the “Parent”) and our subsidiaries that are guarantors of our senior unsecured notes (the “Guarantor Subsidiaries”) is shown below on a combined basis as the “Obligor Group.” The Company’s senior unsecured notes are guaranteed by certain of our wholly-owned domestic subsidiaries and rank equally in right of payment with all of our existing and financial information of the Obligor Group. All intercompany balances and transactions between the Parent and Guarantor Subsidiaries have been eliminated and all information excludes subsidiaries that are not issuers or guarantors of our senior unsecured notes, including earnings from and investments in these entities.

December 31, 2024September 30, 2024
Combined Balance Sheets Information:
Current assets (1)
$1,912.0 $2,077.4 
Non-current assets6,435.0 6,453.1 
Current liabilities810.6 753.3 
Non-current liabilities1,620.0 1,591.6 
Three Months Ended
December 31, 2024
Combined Statements of Operations Information:
Net revenue (2)
$167.8 
Gross profit49.0 
Consolidated net income from continuing operations attributable to Obligors30.0 
Total loss from discontinued operations (net of income tax expense) attributable to Obligors— 
Net income attributable to Obligors30.0 
(1) Current assets include intercompany receivables from non-guarantors of $1,266.1 as of December 31, 2024 and $1,487.7 as of September 30, 2024.
(2) Net revenue includes intercompany sales with non-guarantors of $2.8 for the three months ended December 31, 2024.

Recently Adopted and Issued Accounting Standards
 
For a summary of recently issued and adopted accounting standards applicable to us, see Item 1, Note 2 of Part I of this Form 10-Q.

Item 3.                QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

A full discussion of quantitative and qualitative disclosures about market risk may be found in Item 7A of our 2024 Form 10-K for the year ended September 30, 2024, filed with the SEC on November 19, 2024. There have been no material changes in this information since the filing of our 2024 Form 10-K.


32
Item 4.                CONTROLS AND PROCEDURES
 
Our management, with the participation of our President and Chief Executive Officer and our Senior Vice President and Chief Financial Officer (the “Certifying Officers”), evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective.

In the ordinary course of business, we review our system of internal control over financial reporting and make changes to our systems and processes to improve such controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, automating manual processes, and updating existing systems.

There have been no changes in internal control over financial reporting identified in the evaluation for the quarter ended December 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

PART II — OTHER INFORMATION
 
Item 1.                LEGAL PROCEEDINGS
 
Information pertaining to legal proceedings can be found in Note 13 to the Consolidated Financial Statements included in Part I, Item 1 of this Form 10-Q.
 
Item 1A.                RISK FACTORS

For information regarding the risks we face, see the discussion under Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2024, filed with the SEC on November 19, 2024.


Item 5.                OTHER INFORMATION

(c) Rule 10b5-1 Trading Plans

During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item 6.                EXHIBITS
 
The exhibits filed with this report are listed below.  In reviewing any agreements included as exhibits to this report, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about us or the other parties to the agreements.  The agreements may contain representations and warranties by the parties to the agreements, including us.  Except where explicitly stated otherwise, these representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:
 
•should not necessarily be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
•may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
•may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
•were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
 
33
Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time.

 Restated and Amended Articles of Incorporation of Hillenbrand, Inc., effective as of February 13, 2020 (Incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed February 14, 2020)
 Amended and Restated Code of By-Laws of Hillenbrand, Inc., effective as of April 26, 2024 (Incorporated by reference to Exhibit 3.2 to Current Report on Form 10-Q filed April 30, 2024)
List of Guarantor Subsidiaries of Hillenbrand, Inc. (Incorporated by reference to Exhibit 22 to Annual Report on Form 10-K filed November 19, 2024)
*Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101 The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2024, formatted in Inline XBRL: (i) Consolidated Statements of Operations, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Shareholders’ Equity, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
Exhibit 104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*    Filed herewith.

34
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 HILLENBRAND, INC.
  
Date: February 5, 2025By:/s/ Robert M. VanHimbergen
  Robert M. VanHimbergen
  Senior Vice President and Chief Financial Officer
Date: February 5, 2025/s/ Megan A. Walke
Megan A. Walke
Vice President, Corporate Controller and Chief Accounting Officer


35

EXHIBIT 31.1
 
CERTIFICATIONS
 
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Kimberly K. Ryan, certify that:
 
1. I have reviewed this Quarterly Report on Form 10-Q of Hillenbrand, Inc.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.)          designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.)          designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c.)           evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.)          disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.)          all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.)          any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:  February 5, 2025
 
/s/ Kimberly K. Ryan 
Kimberly K. Ryan 
President and Chief Executive Officer 


EXHIBIT 31.2
 
CERTIFICATIONS
 
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
I, Robert M. VanHimbergen, certify that:
 
1. I have reviewed this Quarterly Report on Form 10-Q of Hillenbrand, Inc.;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.)          designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.)          designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c.)           evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.)          disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.)          all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.)          any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:  February 5, 2025
 
/s/ Robert M. VanHimbergen 
Robert M. VanHimbergen 
Senior Vice President and Chief Financial Officer 


EXHIBIT 32.1
 
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Hillenbrand, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly K. Ryan, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)        The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Kimberly K. Ryan 
Kimberly K. Ryan 
President and Chief Executive Officer 
February 5, 2025 
 
A signed original of this written statement required by Section 906 has been provided to Hillenbrand, Inc. and will be retained by Hillenbrand, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



EXHIBIT 32.2
 
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
In connection with the Quarterly Report of Hillenbrand, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert M. VanHimbergen, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)        The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Robert M. VanHimbergen 
Robert M. VanHimbergen 
Senior Vice President and Chief Financial Officer 
February 5, 2025 
 
A signed original of this written statement required by Section 906 has been provided to Hillenbrand, Inc. and will be retained by Hillenbrand, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


v3.25.0.1
Cover Page - shares
 3 Months Ended
Dec. 31, 2024
Jan. 31, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2024  
Document Transition Report false  
Entity File Number 001-33794  
Entity Registrant Name HILLENBRAND, INC.  
Entity Incorporation, State or Country Code IN  
Entity Tax Identification Number 26-1342272  
Entity Address, Address Line One One Batesville Boulevard  
Entity Address, City or Town Batesville,  
Entity Address, State or Province IN  
Entity Address, Postal Zip Code 47006  
City Area Code 812  
Local Phone Number 931-5000  
Title of 12(b) Security Common Stock, without par value  
Trading Symbol HI  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   70,420,357
Entity Central Index Key 0001417398  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Amendment Flag false  
v3.25.0.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Net revenue $ 706.9 $ 773.3
Cost of goods sold 471.9 522.3
Gross profit 235.0 251.0
Operating expenses 171.1 157.9
Amortization expense 25.2 25.5
Pension settlement (gain) charge (1.7) 8.3
Interest expense, net 25.1 29.8
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total 15.3 29.5
Income tax expense 6.4 10.0
Income from continuing operations 8.9 19.5
Loss from discontinued operations (net of income tax expense) 0.0 (0.3)
Consolidated net income 8.9 19.2
Less: Net income attributable to noncontrolling interests 2.5 2.0
Net income attributable to Hillenbrand $ 6.4 $ 17.2
Basic earnings per share    
Income from continuing operations attributable to Hillenbrand (in dollars per share) $ 0.09 $ 0.25
Income from discontinued operations (in dollars per share) 0 0
Net income attributable to Hillenbrand 0.09 0.25
Diluted earnings per share    
Income from continuing operations attributable to Hillenbrand (in dollars per share) 0.09 0.25
Income from discontinued operations (in dollars per share) 0 (0.01)
Diluted earnings per share $ 0.09 $ 0.24
Weighted average shares outstanding (basic) 70.6 70.3
Weighted average shares outstanding (diluted) 70.6 70.5
v3.25.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]    
Consolidated net income (loss) $ 8.9 $ 19.2
Changes in other comprehensive (loss) income, net of tax:    
Currency translation adjustment (1) (63.9) 49.3
Pension and postretirement 0.8 6.0
Change in net unrealized gain on derivative instruments 27.9 0.9
Total changes in other comprehensive (loss) income, net of tax (35.2) 56.2
Consolidated comprehensive (loss) income (26.3) 75.4
Less: Comprehensive income attributable to noncontrolling interests 1.9 2.0
Comprehensive income (loss) $ (28.2) $ 73.4
v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Current Assets    
Cash and cash equivalents $ 208.0 $ 199.3
Trade receivables, net 309.5 350.1
Receivables from long-term manufacturing contracts, net 289.5 302.7
Inventories, net 521.7 525.2
Prepaid expenses and other current assets 134.0 132.6
Total current assets 1,462.7 1,509.9
Property, plant, and equipment, net 303.7 316.6
Operating lease right-of-use assets, net 157.8 168.7
Intangible assets, net 1,229.4 1,285.9
Goodwill 1,779.1 1,835.7
Other long-term assets 126.7 121.9
Total Assets 5,059.4 5,238.7
Current Liabilities    
Trade accounts payable 405.3 444.8
Liabilities from long-term manufacturing contracts and advances 293.8 315.2
Current portion of long-term debt 20.9 20.6
Accrued compensation 93.1 122.0
Other current liabilities 276.6 286.5
Total current liabilities 1,089.7 1,189.1
Long-term debt 1,885.0 1,872.4
Accrued pension and postretirement healthcare 102.0 109.3
Operating lease liabilities 131.8 141.1
Deferred income taxes 295.5 314.3
Other long-term liabilities 139.0 155.1
Total Liabilities 3,643.0 3,781.3
Commitments and contingencies (Note 13)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 70.4 and 70.2 shares outstanding) 0.0 0.0
Additional paid-in capital 707.6 712.6
Retained earnings 1,035.5 1,045.2
Treasury stock (5400000 and 5600000 shares, at cost) (230.6) (238.2)
Accumulated other comprehensive loss (131.2) (96.6)
Hillenbrand Shareholders’ Equity 1,381.3 1,423.0
Noncontrolling interests 35.1 34.4
Total Shareholders’ Equity 1,416.4 1,457.4
Total Liabilities and Shareholders’ Equity $ 5,059.4 $ 5,238.7
v3.25.0.1
Consolidated Balance Sheets (Parenthetical) - shares
shares in Millions
Dec. 31, 2024
Sep. 30, 2024
Statement of Financial Position [Abstract]    
Common stock, shares issued 75.8 75.8
Common stock, shares outstanding 70.4 70.2
Treasury stock (in shares) 5.4 5.6
v3.25.0.1
Consolidated Statements of Cash Flow - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities from continuing operations    
Consolidated net income $ 8.9 $ 19.2
Adjustments to reconcile income from continuing operations to cash provided by operating activities:    
Loss from discontinued operations (net of income tax expense) 0.0 0.3
Depreciation and amortization 37.9 38.8
Deferred income taxes (4.8) (22.4)
Amortization of deferred financing costs 1.2 1.1
Share-based compensation 4.7 5.2
Trade accounts receivable, net and receivables from long-term manufacturing contracts 17.2 36.7
Inventories, net (13.3) (1.7)
Prepaid expenses and other current assets (3.6) (22.0)
Trade accounts payable (23.8) (38.9)
accrued compensation, and other current liabilities (25.8) (57.7)
Income taxes payable (8.9) 14.9
Accrued pension and postretirement (0.5) 6.5
Other, net (0.5) (4.0)
Net cash used in operating activities from continuing operations (11.3) (24.0)
Investing activities from continuing operations    
Capital expenditures (10.2) (12.4)
Proceeds from sales of property, plant, and equipment 0.5 0.1
Proceeds From Cross-Currency Swap Settlement 9.1 0.0
Collection of deferred purchase price receivables 10.1 0.0
Other, net 0.0 2.8
Net cash provided by (used in) investing activities from continuing operations 9.5 (15.1)
Financing activities from continuing operations    
Repayments on long-term debt (4.9) (2.5)
Proceeds from revolving credit facilities 119.6 31.4
Repayments on revolving credit facilities (68.2) (24.2)
Payments of dividends on common stock (15.8) (15.6)
Proceeds from stock option exercises 0.8 0.6
Payments for employee taxes on net settlement equity awards (3.2) (5.3)
Other, net (1.5) (1.5)
Net cash provided by (used in) financing activities from continuing operations 26.8 (17.1)
Cash provided by (used in) continuing operations 25.0 (56.2)
Cash used in discontinued operations:    
Operating cash flows 0.0 0.0
Investing cash flows 0.0 0.0
Total cash used in discontinued operations 0.0 0.0
Effect of exchange rates on cash and cash equivalents (14.4) 5.6
Net cash flows 10.6 (50.6)
Cash, cash equivalents, and restricted cash:    
At beginning of period 227.9 250.2
At end of period $ 238.5 $ 199.6
v3.25.0.1
Consolidated Statements of Shareholders Equity Statement - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Balance, shares at Sep. 30, 2023   75.8     5.9    
Balance at Sep. 30, 2023 $ 1,662.9   $ 709.5 $ 1,319.6 $ (251.7) $ (147.1) $ 32.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total other comprehensive income (loss), net of tax 56.2         56.2 0.0
Income from continuing operations 19.2     17.2     2.0
Common stock, shares issued         (0.2)    
Issuance/retirement of stock for stock awards/options (4.7)   (13.7)   $ 9.0    
Share-based compensation 5.2   5.2        
Dividends, Common Stock (16.8)   0.2 (15.8)     (1.2)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests (3.0)           (3.0)
Balance at Dec. 31, 2023 1,719.0   701.2 1,321.0 $ (242.7) (90.9) 30.4
Balance, shares at Dec. 31, 2023   75.8     5.7    
Balance, shares at Sep. 30, 2024   75.8     5.6    
Balance at Sep. 30, 2024 1,457.4   712.6 1,045.2 $ (238.2) (96.6) 34.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Total other comprehensive income (loss), net of tax (35.2)         (34.6) (0.6)
Income from continuing operations 8.9     6.4     2.5
Common stock, shares issued         (0.2)    
Issuance/retirement of stock for stock awards/options (2.4)   (10.0)   $ 7.6    
Share-based compensation 4.7   4.7        
Dividends, Common Stock (17.0)   0.3 (16.1)     (1.2)
Balance at Dec. 31, 2024 $ 1,416.4   $ 707.6 $ 1,035.5 $ (230.6) $ (131.2) $ 35.1
Balance, shares at Dec. 31, 2024   75.8     5.4    
v3.25.0.1
Statement of Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]    
Common Stock, Dividends, Per Share, Cash Paid $ 0.225 $ 0.2225
v3.25.0.1
Background and Basis of Presentation
 3 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Basis of Presentation Background and Basis of Presentation
 
Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for TomorrowTM, we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements.

On February 1, 2023, the Company completed the divestiture of its historical Batesville reportable operating segment (“Batesville”) to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $761.5, including an $11.5 subordinated note.

This divestiture represented a strategic shift in Hillenbrand’s business and qualified as a discontinued operation. Accordingly, the operating results and cash flows related to Batesville have been reflected as discontinued operations in the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for all periods presented. Unless otherwise noted, discussion within the condensed notes to the Consolidated Financial Statements relates to continuing operations only and excludes Batesville.

Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. Advanced Process Solutions is a leading global provider of highly-engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions is a global leader in highly-engineered equipment, systems, and aftermarket parts and service for the plastic technology processing industry. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, hot runner systems, process control systems, mold bases and components, and maintenance, repair, and operating (“MRO”) supplies.
 
The Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include three subsidiaries where the Company’s ownership percentage is less than 100%.  The Company’s fiscal year ends on September 30.  Unless otherwise stated, references to years refer to fiscal years.
 
These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2024, as filed with the SEC on November 19, 2024. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the consolidated results of operations to be expected for the full fiscal year.
 
The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period.  Actual results could differ from those estimates.  Examples of such estimates include, but are not limited to, revenue recognition under the over time method, establishment of reserves related to credit losses, warranties, income taxes, litigation, and self-insurance.
v3.25.0.1
Summary of Significant Accounting Policies
 3 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
 
The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2024.
Recently issued accounting standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025), and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements.
 
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements.

In March 2024, the SEC adopted final rules requiring public entities to provide certain climate-related information in their registration statements and annual reports. As part of the disclosures, entities will be required to quantify certain effects of severe weather events and other natural conditions in a note to their audited financial statements. The rules will be effective for annual periods beginning in calendar 2025 (fiscal 2026). In April 2024, the SEC voluntarily stayed implementation of the final rules pending certain legal challenges. The Company is assessing the effect of the new rules on our Consolidated Financial Statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires, among other items, additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the Consolidated Statement of Operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 (fiscal 2028), and for interim periods within fiscal years beginning after December 15, 2027 (fiscal 2029), with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on the Consolidated Financial Statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.
v3.25.0.1
Revenue Recognition
 3 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers.

Contract balances

The balance in receivables from long-term manufacturing contracts at December 31, 2024 and September 30, 2024, was $289.5 and $302.7, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2024 and September 30, 2024, was $293.8 and $315.2, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the three months ended December 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2024 and 2023, was $95.6 and $116.4, respectively. During the three months ended December 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Transaction price allocated to the remaining performance obligations
                                            
As of December 31, 2024, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Quarterly Report on Form 10-Q, was $1,816.7. Approximately 88% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years.
Disaggregation of revenue

The following tables present net revenue by geography:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Geography (1)
Americas$229.2 $102.9 $332.1 $264.2 $109.9 $374.1 
Asia128.8 60.2 189.0 146.3 60.5 206.8 
Europe, the Middle East, and Africa153.1 32.7 185.8 157.8 34.6 192.4 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 
(1)The Company attributes net revenue to a geography based upon the location of the end customer.

The following tables present net revenue by timing of transfer:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Timing of transfer
Point in time$269.8 $181.1 $450.9 $278.2 $186.4 $464.6 
Over time241.3 14.7 256.0 290.1 18.6 308.7 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 
v3.25.0.1
Supplemental Balance Sheet Information
 3 Months Ended
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Supplemental Balance Sheet Information Supplemental Consolidated Balance Sheet Information
December 31, 2024September 30, 2024
Allowance for credit losses$13.7 $13.6 
Warranty reserves$46.7 $47.9 
Accumulated depreciation on property, plant, and equipment$268.7 $265.6 
Inventories, net:  
Raw materials and components$248.1 $247.0 
Work in process120.1 127.6 
Finished goods153.5 150.6 
Total inventories, net$521.7 $525.2 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:
December 31, 2024December 31, 2023
Cash and cash equivalents$208.0 $198.4 
Short-term restricted cash included in other current assets6.9 1.2 
Long-term restricted cash included in other long-term assets23.6 — 
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows$238.5 $199.6 

Equity Method Investment

The Consolidated Financial Statements include our 46% interest in TerraSource Holdings, LLC (“Holdings”), which is accounted for using the equity method of accounting as we have significant influence over the operating and financial policies of Holdings; however, we do not control Holdings. When we record our proportionate share of net income, we record it as a reduction to Operating expenses in the Consolidated Statements of Operations and increase the carrying value of our equity method investment. Conversely, when we record our proportionate share of a net loss, if applicable, we record it within Operating expenses in the Consolidated Statements of Operations and decrease the carrying value of our equity method investment. The value of our equity method investment in Holdings, which is recorded in Other long-term assets, was $12.0 and $9.2 at December 31, 2024 and September 30, 2024, respectively. We recorded our proportionate share of net income of Holdings of $2.8 and $1.5 for the three months ended December 31, 2024 and 2023, respectively, as a reduction of Operating expenses.

Supplier Finance Program

The Company has an agreement with a third-party to facilitate a supply chain finance (“SCF”) program with participating financial institutions. The SCF program allows qualifying suppliers to sell their receivables, on an invoice level at the selection of the supplier, from the Company to the financial institutions and negotiate their outstanding receivable arrangements and associated fees directly with the financial institutions. Hillenbrand is not party to the agreements between the supplier and the financial institutions. The supplier invoices that have been confirmed as valid under the SCF program require payment in full by the financial institutions to the supplier by the original maturity date of the invoice, or discounted payment at an earlier date as agreed upon with the supplier. The Company’s obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by a supplier’s participation in the SCF program.
 
All outstanding amounts related to suppliers participating in the SCF program are recorded upon confirmation with the third-party financial institutions in trade accounts payable in the Consolidated Balance Sheets, and associated payments are included in cash used in operating activities in the Consolidated Statements of Cash Flows. The Company’s outstanding obligations included in trade accounts payable as of December 31, 2024 and September 30, 2024, were $14.4 and $16.0, respectively.

Trade Receivables Financing Agreements

The Company sells a small percentage of its trade receivables to outside financial institutions in the normal course of business. These trade receivable financing agreements are accounted for as a true sale of assets under the provisions of Accounting Standards Codification (“ASC”) 860, Transfer and Servicing (“ASC 860”). During fiscal 2024, the Company executed an amendment of one of its trade receivables financing agreement (as amended, the “Amended Agreement”) with a financial institution. In accordance with ASC 860 this Amended Agreement is deemed a true sale, as the Company retains no rights or interest and has no obligations with respect to the trade receivables, and has no continuing involvement with the trade receivables once transferred to the financial institution. As part of the Amended Agreement, we receive the majority of the proceeds of the trade receivables sold to the financial institution upon sale in cash (level 1 fair value measurement) with the remaining portion of the proceeds held by the financial institution as a deferred purchase price (“DPP”) (level 2 fair value measurement) until the collection of the trade receivables sold. The DPP receivables are ultimately realized by the Company following the collection of the underlying trade receivables sold to the financial institution (typically within 90 - 120 days). As defined in the Amended Agreement, the financial institution is responsible for any credit risk associated with the sold trade receivables. There is no limit on the amount of trade receivables that can be sold under the Amended Agreement; however, all trade receivables must be accepted by the financial institution prior to sale.

Sales of trade receivables under the Amended Agreement and other trade receivable factoring arrangements were $70.8 and $7.2 for the three months ended December 31, 2024 and 2023, respectively, and cash collections from customers on trade receivables sold were $71.7 and $7.2 during the three months ended December 31, 2024 and 2023, respectively. The Company acts as a servicer (collects customer cash on behalf of the financial institution) for one of its trade receivables factoring arrangements. The servicing fee associated with this trade receivables factoring arrangement was not material to the Company for the three months ended December 31, 2024 and 2023, respectively. Amounts collected on behalf of the financial institution under this trade receivables factoring arrangement and owed to the financial institution were $2.2 and $3.1 at December 31, 2024 and September 30, 2024, respectively. The loss on the sale of trade receivables under the Amended Agreement and other trade receivables factoring arrangements was not material to the Company for the three months ended December 31, 2024 and 2023. As of December 31, 2024 and September 30, 2024, trade receivables in the amount of $28.5 and $34.2, respectively were sold to the financial institution and are not reflected in trade receivables in the Consolidated Balance Sheets.

The following roll forward summarizes the activity related to the DPP receivables:

Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Beginning DPP receivables balance$6.7 $— 
Non-cash additions to DPP receivables9.2 — 
Cash collections on DPP receivables(10.1)— 
Ending DPP receivables balance$5.8 $— 
v3.25.0.1
Leases
 3 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Leases Leases
For the three months ended December 31, 2024 and 2023, the Company recognized $10.5 and $8.5 of operating lease expense, respectively, including short-term lease expense and variable lease costs, which were immaterial in each period. The Company’s finance leases were insignificant as of December 31, 2024 and September 30, 2024.

The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases:
December 31, 2024September 30, 2024
Operating lease right-of-use assets, net$157.8$168.7
Other current liabilities20.522.0
Operating lease liabilities131.8141.1
Total operating lease liabilities$152.3$163.1
Weighted-average remaining lease term (in years)10.110.3
Weighted-average discount rate6.3 %6.3 %

As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows:
2025 (excluding the three months ended December 31, 2024)
$21.4 
202625.9 
202723.0 
202820.8 
202919.2 
Thereafter111.4 
Total lease payments221.7 
Less: imputed interest(69.4)
Total present value of lease payments$152.3 

Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows:
Three Months Ended December 31,
20242023
Cash paid for amounts included in the measurement of operating lease liabilities$8.0 $6.8 
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities4.6 4.9 
Operating leases acquired in business combinations— 3.5 
v3.25.0.1
Intangible Assets and Goodwill
 3 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill Intangible Assets and Goodwill
Intangible Assets

Intangible assets are stated at the lower of cost or fair value. Intangible assets are amortized on a straight-line basis over periods ranging from three to 21 years, representing the period over which the Company expects to receive future economic benefits from these assets. The Company assesses the carrying value of indefinite-lived trade names annually, or more often if events or changes in circumstances indicate there may be an impairment.
The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of:

 December 31, 2024September 30, 2024
 CostAccumulated
Amortization		CostAccumulated
Amortization
Finite-lived assets:    
Customer relationships$1,278.6 $(386.8)$1,316.9 $(379.4)
Technology, including patents189.3 (101.8)192.3 (100.9)
Software56.4 (38.9)53.0 (35.3)
Trade names50.2 (11.5)52.5 (10.6)
 1,574.5 (539.0)1,614.7 (526.2)
Indefinite-lived assets:    
Trade names193.9 — 197.4 — 
Total$1,768.4 $(539.0)$1,812.1 $(526.2)

Finite-lived intangible assets, net of $658.6 and $693.0 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $108.8 and $112.3 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. The net change in intangible assets in the Advanced Process Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments.

Finite-lived intangible assets, net of $369.7 and $388.3 are included in the Molding Technology Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $85.1 are included in the Molding Technology Solutions reportable operating segment at both December 31, 2024 and September 30, 2024. The net change in intangible assets in the Molding Technology Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments.

Goodwill

Goodwill is not amortized, but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment.  Impairment testing is performed at a reporting unit level.

The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2024:
 Advanced Process SolutionsMolding Technology SolutionsTotal
Balance as of September 30, 2024$1,430.2 $405.5 $1,835.7 
Foreign currency adjustments(48.7)(7.9)(56.6)
Balance as of December 31, 2024
$1,381.5 $397.6 $1,779.1 

During the three months ended December 31, 2024 and 2023, the Company did not observe any triggering events or substantive changes in circumstances requiring the need for an interim impairment assessment.
v3.25.0.1
Financing Agreements
 3 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Financing Agreements Financing Agreements
The following table summarizes Hillenbrand’s current and long-term debt as of:
December 31, 2024September 30, 2024
$1,000 revolving credit facility (excluding outstanding letters of credit)
$329.0 $298.5 
$200 term loan
180.0 182.5 
€185 term loan
180.9 196.5 
$500 senior unsecured notes (1)
495.0 494.6 
$375 senior unsecured notes (2)
373.8 373.6 
$350 senior unsecured notes (3)
347.2 347.1 
Other— 0.2 
Total debt1,905.9 1,893.0 
Less: current portion 20.9 20.6 
Total long-term debt$1,885.0 $1,872.4 
(1)Includes unamortized debt issuance costs of $5.0 and $5.4 at December 31, 2024 and September 30, 2024, respectively.
(2)Includes unamortized debt issuance costs of $1.0 and $1.2 at December 31, 2024 and September 30, 2024, respectively.
(3)Includes unamortized debt issuance costs of $2.8 and $2.9 at December 31, 2024 and September 30, 2024, respectively.

As of December 31, 2024, the Company had $17.7 in outstanding letters of credit issued and $653.3 of borrowing capacity under the revolving credit facility (the “Facility”), of which $424.3 was immediately available based on the Company’s most restrictive covenant. The weighted-average interest rate on borrowings under the Facility was 4.96% and 5.84% for the three months ended December 31, 2024 and 2023, respectively. The weighted average facility fee on the Facility was 0.24% and 0.20% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the $200 term loan was 6.69% and 5.60% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the €185 term loan was 5.05% and 5.60% for the three months ended December 31, 2024 and 2023, respectively.

Remaining unamortized deferred financing costs related to the Facility, $200 term loan and €185 term loan were $5.0 in aggregate, as of December 31, 2024, and are being amortized to interest expense over the remaining term of these agreements.

In the normal course of business, the Company provides, primarily to certain customers, bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of December 31, 2024 and September 30, 2024, the Company had credit arrangements totaling $561.3 and $594.3, respectively, under which $331.7 and $400.2, respectively, were used for guarantees. These arrangements include the Company’s Syndicated L/G Facility Agreement (“L/G Facility”) and other ancillary credit facilities. Remaining unamortized deferred financing costs related to the L/G Facility were $1.4 as of December 31, 2024, and are being amortized to interest expense over the remaining term of the agreement.

As of December 31, 2024, Hillenbrand was in compliance with all covenants contained in the foregoing agreements and credit instruments and there were no events of default.
v3.25.0.1
Retirement Benefits
 3 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Retirement Benefits Retirement Benefits
 
Defined Benefit Plans

Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows:
 
U.S. Pension BenefitsNon-U.S. Pension Benefits
Three Months Ended December 31,Three Months Ended December 31,
 2024202320242023
Service costs$— $— $0.7 $0.5 
Interest costs0.2 2.0 0.8 1.1 
Expected return on plan assets— (2.7)(0.3)(0.4)
Amortization of net loss (gain)— 0.1 (0.2)(0.2)
Settlement (gain) charge(1.7)8.3 — — 
Net periodic pension (benefit) cost$(1.5)$7.7 $1.0 $1.0 

On July 18, 2023, we announced an offer to provide former employees who are participants in the Company’s U.S. defined benefit pension plan (the “Plan”) the opportunity to elect a lump sum distribution of their earned Plan benefits. The Plan’s fiduciaries made lump sum payments to electing eligible participants in December 2023, funded by the existing assets in the Plan. In April 2024, the remaining assets of the Plan were used to purchase annuities to support the remaining obligation, resulting in the termination and liquidation of the Plan. During the three months ended December 31, 2024, the Company received one-time premium refunds of $1.7 related to the termination of the Plan, which was recorded as a pretax pension settlement gain on the Consolidated Statement of Operations. During the three months ended December 31, 2023, the Company recorded a non-cash settlement pre-tax charge of $8.3, related to the termination and liquidation of the Plan.

Defined Contribution Plans
Expenses related to the Company’s defined contribution plans were $3.1 and $2.9 for the three months ended December 31, 2024, and 2023, respectively
v3.25.0.1
Income Taxes
 3 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
 
The effective tax rates for the three months ended December 31, 2024 and 2023 were 41.8% and 33.9%, respectively. The increase in the effective tax rate was primarily driven by an increase in unrecognized tax benefits, the expiration of a reduced incentive tax rate for certain operations located in China, and a reduced discrete tax benefit for equity compensation, partially offset by the revaluation of Canadian deferred tax liabilities as a result of currency fluctuation, and a reduction of the tax accrual for unrepatriated earnings.
v3.25.0.1
Earnings Per Share
 3 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings per share
The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective Consolidated Balance Sheet date.  Potential dilutive effects, representing approximately 630,000 and 440,000 shares at December 31, 2024 and 2023, respectively, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.
Three Months Ended
December 31,
 20242023
Income from continuing operations$8.9 $19.5 
Less: Net income attributable to noncontrolling interests2.5 2.0 
Income from continuing operations attributable to Hillenbrand$6.4 $17.5 
Weighted-average shares outstanding (basic - in millions)70.6 70.3 
Effect of dilutive stock options and other unvested equity awards (in millions)— 0.2 
Weighted-average shares outstanding (diluted - in millions)70.6 70.5 
Basic earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Diluted earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)0.9 0.6 
v3.25.0.1
Accumulated Other Comprehensive Loss
 3 Months Ended
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss:
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2024$(15.6)$(55.4)$(25.6)$(96.6)  
Other comprehensive loss before reclassifications:      
Before tax amount1.1 (63.3)26.5 (35.7)$(0.6)$(36.3)
Tax benefit (0.3)— 0.7 0.4 — 0.4 
After tax amount0.8 (63.3)27.2 (35.3)(0.6)(35.9)
Amounts reclassified from accumulated other comprehensive loss (2)
— — 0.7 0.7 — 0.7 
Net current period other comprehensive income (loss)0.8 (63.3)27.9 (34.6)$(0.6)$(35.2)
Balance at December 31, 2024$(14.8)$(118.7)$2.3 $(131.2)  
(1)Includes gain and losses on intra-entity foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2023$(34.5)$(107.1)$(5.5)$(147.1)  
Other comprehensive income before reclassifications:      
Before tax amount(0.4)49.3 0.3 49.2 $— $49.2 
Tax benefit0.2 — (0.1)0.1 — 0.1 
After tax amount(0.2)49.3 0.2 49.3 — 49.3 
Amounts reclassified from accumulated other comprehensive loss (2)
6.2 — 0.7 6.9 — 6.9 
Net current period other comprehensive income 6.0 49.3 0.9 56.2 $— $56.2 
Balance at December 31, 2023$(28.5)$(57.8)$(4.6)$(90.9)  
(1)Includes gains and losses on intra-foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.

Reclassifications out of accumulated other comprehensive loss include: 
 Three Months Ended December 31, 2024
 
Amortization of Pension and
Postretirement (1)
Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $0.3 $0.3 
Operating expenses— — 0.5 0.5 
Total before tax$— $— $0.8 $0.8 
Tax expense(0.1)
Total reclassifications for the period, net of tax$0.7 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

 Three Months Ended December 31, 2023
 
Amortization of Pension and
Postretirement (1)
(Gain) Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $(0.1)$(0.1)
Cost of goods sold— — 0.3 0.3 
Operating expenses8.2 — 0.5 8.7 
Total before tax$8.2 $— $0.7 $8.9 
Tax expense(2.0)
Total reclassifications for the period, net of tax$6.9 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).
v3.25.0.1
Share-Based Compensation
 3 Months Ended
Dec. 31, 2024
Compensation Related Costs [Abstract]  
Share-Based Compensation Share-Based Compensation
Three Months Ended
December 31,
 20242023
Share-based compensation costs $4.7 $5.2 
Less impact of income taxes1.1 1.2 
Share-based compensation costs, net of tax$3.6 $4.0 
 
The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value, as well as time-based awards. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated stock index. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period.  For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants. 
 
During the three months ended December 31, 2024, the Company made the following grants:
 
 Number of
Units
Time-based stock awards354,713 
Performance-based stock awards (maximum that can be earned)588,686 
 
The Company’s time-based stock awards and performance-based stock awards granted during the three months ended December 31, 2024, had weighted-average grant date fair values of $33.62 and $40.06, respectively. Included in the performance-based stock awards granted during the three months ended December 31, 2024 are 294,386 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above.  These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.
v3.25.0.1
Commitments and Contingencies
 3 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
 
From time to time, Hillenbrand is involved in claims, lawsuits, and government proceedings relating to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment-related, and other matters.  The ultimate outcome of any claims, lawsuits, and proceedings cannot be predicted with certainty.  An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters.  If a loss is not considered probable or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred.  Legal fees associated with claims and lawsuits are generally expensed as incurred.
 
Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period.  For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary often provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses.  For all other types of claims, reserves are established when payment is considered probable and are based upon advice from internal and external counsel and historical settlement information for such claims.
 
The recorded amounts represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates.

At December 31, 2024 and September 30, 2024, the Company had $11.2, included in other current liabilities on the Consolidated Balance Sheets, related to a discrete commercial dispute stemming from a contract entered into with a Molding Technology Solutions’ customer prior to the Company’s acquisition of the Molding Technology Solutions reportable operating segment.
v3.25.0.1
Fair Value Measurements
 3 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
 
Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date.  The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available.  Observable inputs are from sources independent of the Company.  Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances.  The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.  The hierarchy is broken down into three levels:
 
Level 1:Inputs are quoted prices in active markets for identical assets or liabilities.
Level 2:Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly.
Level 3:Inputs are unobservable for the asset or liability.
 
See the section below titled “Valuation techniques” for further discussion of how Hillenbrand determines fair value for certain assets and liabilities.
Carrying Value at December 31, 2024
Fair Value at December 31, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$208.0 $208.0 $— $— 
DPP receivables5.8 — 5.8 — 
Restricted cash1.0 1.0 — — 
Restricted cash for benefit plan contributions29.5 29.5 — — 
Investments in rabbi trust5.5 5.5 — — 
Derivative instruments22.3 — 22.3 — 
Liabilities:
Revolving credit facility329.0 — 329.0 — 
$200 term loan
180.0 — 180.0 — 
€185 term loan
180.9 — 180.9 — 
$350 senior unsecured notes
350.0 306.2 — — 
$375 senior unsecured notes
374.8 372.1 — — 
$500 senior unsecured notes
500.0 501.4 — — 
Derivative instruments28.1 — 28.1 — 
Contingent consideration14.6 — — 14.6 
 
 
Carrying Value at September 30, 2024
Fair Value at September 30, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$199.3 $199.3 $— $— 
DPP receivables6.7 — 6.7 — 
Restricted cash1.1 1.1 — — 
Restricted cash for benefit plan contributions27.5 27.5 — — 
Investments in rabbi trust4.8 4.8 — — 
Derivative instruments19.0 — 19.0 — 
Liabilities:    
Revolving credit facility298.5 — 298.5 — 
$200 term loan
182.5 — 182.5 — 
€185 term loan
196.5 — 196.5 — 
$350 senior unsecured notes
350.0 312.9 — — 
$375 senior unsecured notes
374.8 373.7 — — 
$500 senior unsecured notes
500.0 509.8 — — 
Derivative instruments40.5 — 40.5 — 
Contingent consideration14.6 — — 14.6 

Valuation techniques
 
•Cash and cash equivalents, restricted cash, restricted cash for benefit plan contributions, and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments.
•The DPP receivables fair value is based on a discounted cash flow analysis (estimated amount expected to be received) using historical experience and inputs from similar programs, which include the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the inputs in isolation would not result in a materially different fair value estimate. Based on the short-term nature of the DPP receivables, typically 90 -120 days, they are classified as a level 2 measurement.
•The Company estimates the fair value of foreign currency derivatives using industry accepted models.  The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility.  These inputs were obtained from pricing services, broker quotes, and other sources.
•The fair values of the amounts outstanding under the Facility, $200 term loan, and €185 term loan approximate carrying value, as the Company believes their variable interest rate terms correspond to current market terms, and therefore, are classified within Level 2 of the fair value hierarchy.
•The fair values of the $350 senior unsecured notes, $375 senior unsecured notes, and $500 senior unsecured notes were based on quoted prices in active markets and are classified within Level 1 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments.
•The contingent consideration of $14.6 reflects the estimated fair value of contingent future cash payments to the previous owners of FPM for research and development tax credits that were generated by FPM prior to the acquisition date. The Company estimated the fair value of the contingent consideration based on the technical merits of the research and development tax credits using an internally developed analysis. The key inputs to this calculation include the nature of the research and development activities, personnel involved in the research and development activities, the level of research and development spend prior to acquisition by the Company, and interpretation of applicable tax law. The value of these credits is subject to audit by the tax authorities and to the closing of the statute of limitations for the year in which the tax credits are fully utilized, the timing of which is not able to be determined at this time, but we expect to extend several years. There have been no changes in the estimated fair value of the initial calculation of the contingent consideration during the three months ended December 31, 2024. The inputs for the liability are unobservable, and therefore, are classified within Level 3 of the fair value hierarchy.
Derivative instruments

Hillenbrand participates in cross-currency swap agreements aiming to hedge the variability in the movement of foreign currency exchange rates for its operations in Europe, while simultaneously lowering the Company’s overall borrowing costs. The maturity dates of these agreements range from 2027 to 2029. These agreements qualify for hedge accounting and accordingly the changes in the fair value of the derivatives are recorded in other comprehensive (loss) income and remain in accumulated other comprehensive loss attributable to Hillenbrand in shareholders’ equity until the hedged item is recognized in earnings. We assess the effectiveness of cross-currency swap contracts using the spot method, and the difference between the interest rate received and paid under the cross-currency swap agreements is recorded in interest expense, net, in the Consolidated Statements of Operations. As a result of participating in these cross-currency swap agreements, Hillenbrand recorded a reduction in interest expense, net of $3.2 and $0.0 during the three months ended December 31, 2024 and 2023, respectively. Hillenbrand presents the cross-currency swap agreements’ periodic settlements in operating activities in the Consolidated Statements of Cash Flows.

The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months.
The aggregate notional value of the cross-currency swap agreements was $691.9 and $727.8 at December 31, 2024 and September 30, 2024, respectively. The aggregate notional value of the foreign currency exchange forward contract derivatives was $262.4 and $172.5 at December 31, 2024 and September 30, 2024, respectively. The derivatives are recorded at fair value in prepaid expenses and other current assets, other current liabilities, and other long-term liabilities in the Consolidated Balance Sheets.
v3.25.0.1
Segment and Geographical Information
 3 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment and Geographical Information Segment and Geographical Information
As previously described, on February 1, 2023, the Company completed the divestiture of Batesville. The operating results and cash flows for Batesville have been classified as discontinued operations within the Consolidated Financial Statements for all periods presented.

Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. The Company’s reportable operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance.

The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs.  Corporate provides management and administrative services to each reportable operating segment.  These services include treasury management, human resources, legal, business development, information technology, tax compliance, global supply management, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting.  With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments.
The following tables present financial information for the Company’s reportable operating segments and significant geographical locations:
 Three Months Ended December 31,
 20242023
Net revenue
Advanced Process Solutions$511.1 $568.3 
Molding Technology Solutions195.8 205.0 
Total$706.9 $773.3 
Adjusted EBITDA (1)
Advanced Process Solutions$82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Net revenue (2)
United States$284.7 $326.9 
China81.1 91.9 
India57.1 57.9 
Germany51.1 59.1 
All other countries232.9 237.5 
Total$706.9 $773.3 
 
(1)Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP financial measure used by management to measure segment performance and make operating decisions.
(2)The Company attributes net revenue to a geography based upon the location of the end customer.

 December 31, 2024September 30, 2024
Total assets  
Advanced Process Solutions$3,331.7 $3,470.8 
Molding Technology Solutions1,551.2 1,600.0 
Corporate176.5 167.9 
Total$5,059.4 $5,238.7 
Tangible long-lived assets, net  
United States$184.1 $186.1 
Germany123.5 134.5 
China 34.8 37.1 
India33.9 35.6 
All other foreign business units85.2 92.0 
Total$461.5 $485.3 
The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income:
 Three Months Ended
December 31,
20242023
Adjusted EBITDA:
Advanced Process Solutions $82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Add:
Loss from discontinued operations (net of income tax expense)— (0.3)
Less:
Interest expense, net25.1 29.8 
Income tax expense6.4 10.0 
Depreciation and amortization37.9 38.8 
Pension settlement (gain) charge(1.7)8.3 
Business acquisition, divestiture, and integration costs18.1 5.6 
Inventory step-up costs— 1.5 
Restructuring and restructuring-related charges 2.4 0.6 
Consolidated net income$8.9 $19.2 
v3.25.0.1
Subsequent Events
 3 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events
16.Subsequent Event
On February 5, 2025, the Company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection molding and extrusion business to an affiliate of Bain Capital, while retaining an approximate 49% ownership stake. The purchase price is expected to be $287.0, subject to customary adjustments, and will be paid in cash. The Company expects the transaction to close in the second or third quarter of 2025.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ 6.4 $ 17.2
v3.25.0.1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
New Accounting Pronouncements, Policy
Recently issued accounting standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025), and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements.
 
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements.

In March 2024, the SEC adopted final rules requiring public entities to provide certain climate-related information in their registration statements and annual reports. As part of the disclosures, entities will be required to quantify certain effects of severe weather events and other natural conditions in a note to their audited financial statements. The rules will be effective for annual periods beginning in calendar 2025 (fiscal 2026). In April 2024, the SEC voluntarily stayed implementation of the final rules pending certain legal challenges. The Company is assessing the effect of the new rules on our Consolidated Financial Statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires, among other items, additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the Consolidated Statement of Operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 (fiscal 2028), and for interim periods within fiscal years beginning after December 15, 2027 (fiscal 2029), with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on the Consolidated Financial Statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.
Revenue
Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers.
Revenue Recognition, Deferred Revenue
Contract balances

The balance in receivables from long-term manufacturing contracts at December 31, 2024 and September 30, 2024, was $289.5 and $302.7, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2024 and September 30, 2024, was $293.8 and $315.2, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the three months ended December 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2024 and 2023, was $95.6 and $116.4, respectively. During the three months ended December 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial.
v3.25.0.1
Revenue Recognition (Tables)
 3 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
Disaggregation of revenue

The following tables present net revenue by geography:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Geography (1)
Americas$229.2 $102.9 $332.1 $264.2 $109.9 $374.1 
Asia128.8 60.2 189.0 146.3 60.5 206.8 
Europe, the Middle East, and Africa153.1 32.7 185.8 157.8 34.6 192.4 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 
(1)The Company attributes net revenue to a geography based upon the location of the end customer.

The following tables present net revenue by timing of transfer:
Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Advanced Process SolutionsMolding Technology SolutionsTotalAdvanced Process SolutionsMolding Technology SolutionsTotal
Timing of transfer
Point in time$269.8 $181.1 $450.9 $278.2 $186.4 $464.6 
Over time241.3 14.7 256.0 290.1 18.6 308.7 
    Total$511.1 $195.8 $706.9 $568.3 $205.0 $773.3 
v3.25.0.1
Supplemental Balance Sheet Information (Tables)
 3 Months Ended
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of supplemental balance sheet information
December 31, 2024September 30, 2024
Allowance for credit losses$13.7 $13.6 
Warranty reserves$46.7 $47.9 
Accumulated depreciation on property, plant, and equipment$268.7 $265.6 
Inventories, net:  
Raw materials and components$248.1 $247.0 
Work in process120.1 127.6 
Finished goods153.5 150.6 
Total inventories, net$521.7 $525.2 

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:
December 31, 2024December 31, 2023
Cash and cash equivalents$208.0 $198.4 
Short-term restricted cash included in other current assets6.9 1.2 
Long-term restricted cash included in other long-term assets23.6 — 
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows$238.5 $199.6 
Fair Value Option, Disclosures
The following roll forward summarizes the activity related to the DPP receivables:

Three Months Ended December 31, 2024Three Months Ended December 31, 2023
Beginning DPP receivables balance$6.7 $— 
Non-cash additions to DPP receivables9.2 — 
Cash collections on DPP receivables(10.1)— 
Ending DPP receivables balance$5.8 $— 
v3.25.0.1
Leases (Tables)
 3 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Supplemental Balance Sheet Information
The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases:
December 31, 2024September 30, 2024
Operating lease right-of-use assets, net$157.8$168.7
Other current liabilities20.522.0
Operating lease liabilities131.8141.1
Total operating lease liabilities$152.3$163.1
Weighted-average remaining lease term (in years)10.110.3
Weighted-average discount rate6.3 %6.3 %
Schedule of Operating Lease Liability Maturities
As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows:
2025 (excluding the three months ended December 31, 2024)
$21.4 
202625.9 
202723.0 
202820.8 
202919.2 
Thereafter111.4 
Total lease payments221.7 
Less: imputed interest(69.4)
Total present value of lease payments$152.3 
Schedule of Supplemental Statement of Cash Flow Information
Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows:
Three Months Ended December 31,
20242023
Cash paid for amounts included in the measurement of operating lease liabilities$8.0 $6.8 
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities4.6 4.9 
Operating leases acquired in business combinations— 3.5 
v3.25.0.1
Intangible Assets and Goodwill (Tables)
 3 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets
The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of:

 December 31, 2024September 30, 2024
 CostAccumulated
Amortization		CostAccumulated
Amortization
Finite-lived assets:    
Customer relationships$1,278.6 $(386.8)$1,316.9 $(379.4)
Technology, including patents189.3 (101.8)192.3 (100.9)
Software56.4 (38.9)53.0 (35.3)
Trade names50.2 (11.5)52.5 (10.6)
 1,574.5 (539.0)1,614.7 (526.2)
Indefinite-lived assets:    
Trade names193.9 — 197.4 — 
Total$1,768.4 $(539.0)$1,812.1 $(526.2)
Schedule of Goodwill
The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2024:
 Advanced Process SolutionsMolding Technology SolutionsTotal
Balance as of September 30, 2024$1,430.2 $405.5 $1,835.7 
Foreign currency adjustments(48.7)(7.9)(56.6)
Balance as of December 31, 2024
$1,381.5 $397.6 $1,779.1 
v3.25.0.1
Financing Agreements (Tables)
 3 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of borrowings under financing agreements
The following table summarizes Hillenbrand’s current and long-term debt as of:
December 31, 2024September 30, 2024
$1,000 revolving credit facility (excluding outstanding letters of credit)
$329.0 $298.5 
$200 term loan
180.0 182.5 
€185 term loan
180.9 196.5 
$500 senior unsecured notes (1)
495.0 494.6 
$375 senior unsecured notes (2)
373.8 373.6 
$350 senior unsecured notes (3)
347.2 347.1 
Other— 0.2 
Total debt1,905.9 1,893.0 
Less: current portion 20.9 20.6 
Total long-term debt$1,885.0 $1,872.4 
(1)Includes unamortized debt issuance costs of $5.0 and $5.4 at December 31, 2024 and September 30, 2024, respectively.
(2)Includes unamortized debt issuance costs of $1.0 and $1.2 at December 31, 2024 and September 30, 2024, respectively.
(3)Includes unamortized debt issuance costs of $2.8 and $2.9 at December 31, 2024 and September 30, 2024, respectively.
v3.25.0.1
Retirement Benefits (Tables)
 3 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Components of net pension costs
Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows:
 
U.S. Pension BenefitsNon-U.S. Pension Benefits
Three Months Ended December 31,Three Months Ended December 31,
 2024202320242023
Service costs$— $— $0.7 $0.5 
Interest costs0.2 2.0 0.8 1.1 
Expected return on plan assets— (2.7)(0.3)(0.4)
Amortization of net loss (gain)— 0.1 (0.2)(0.2)
Settlement (gain) charge(1.7)8.3 — — 
Net periodic pension (benefit) cost$(1.5)$7.7 $1.0 $1.0 
v3.25.0.1
Earnings Per Share (Tables)
 3 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted earnings per share
Three Months Ended
December 31,
 20242023
Income from continuing operations$8.9 $19.5 
Less: Net income attributable to noncontrolling interests2.5 2.0 
Income from continuing operations attributable to Hillenbrand$6.4 $17.5 
Weighted-average shares outstanding (basic - in millions)70.6 70.3 
Effect of dilutive stock options and other unvested equity awards (in millions)— 0.2 
Weighted-average shares outstanding (diluted - in millions)70.6 70.5 
Basic earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Diluted earnings per share from continuing operations attributable to Hillenbrand$0.09 $0.25 
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)0.9 0.6 
v3.25.0.1
Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of changes in accumulated other comprehensive income (loss) by component
The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss:
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2024$(15.6)$(55.4)$(25.6)$(96.6)  
Other comprehensive loss before reclassifications:      
Before tax amount1.1 (63.3)26.5 (35.7)$(0.6)$(36.3)
Tax benefit (0.3)— 0.7 0.4 — 0.4 
After tax amount0.8 (63.3)27.2 (35.3)(0.6)(35.9)
Amounts reclassified from accumulated other comprehensive loss (2)
— — 0.7 0.7 — 0.7 
Net current period other comprehensive income (loss)0.8 (63.3)27.9 (34.6)$(0.6)$(35.2)
Balance at December 31, 2024$(14.8)$(118.7)$2.3 $(131.2)  
(1)Includes gain and losses on intra-entity foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.
 Pension and
Postretirement
Currency
Translation (1)
Net
Unrealized
(Loss) Gain
on Derivative
Instruments		Total
Attributable
to
Hillenbrand,
Inc.		Noncontrolling
Interests		Total
Balance at September 30, 2023$(34.5)$(107.1)$(5.5)$(147.1)  
Other comprehensive income before reclassifications:      
Before tax amount(0.4)49.3 0.3 49.2 $— $49.2 
Tax benefit0.2 — (0.1)0.1 — 0.1 
After tax amount(0.2)49.3 0.2 49.3 — 49.3 
Amounts reclassified from accumulated other comprehensive loss (2)
6.2 — 0.7 6.9 — 6.9 
Net current period other comprehensive income 6.0 49.3 0.9 56.2 $— $56.2 
Balance at December 31, 2023$(28.5)$(57.8)$(4.6)$(90.9)  
(1)Includes gains and losses on intra-foreign currency transactions that are of a long-term investment nature.
(2)Amounts are net of tax.
Schedule of reclassifications of AOCI
Reclassifications out of accumulated other comprehensive loss include: 
 Three Months Ended December 31, 2024
 
Amortization of Pension and
Postretirement (1)
Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $0.3 $0.3 
Operating expenses— — 0.5 0.5 
Total before tax$— $— $0.8 $0.8 
Tax expense(0.1)
Total reclassifications for the period, net of tax$0.7 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

 Three Months Ended December 31, 2023
 
Amortization of Pension and
Postretirement (1)
(Gain) Loss on 
 Net Loss
Recognized		Prior Service Costs
Recognized		Derivative
Instruments		Total
Affected Line in the Consolidated Statement of Operations:    
Net revenue$— $— $(0.1)$(0.1)
Cost of goods sold— — 0.3 0.3 
Operating expenses8.2 — 0.5 8.7 
Total before tax$8.2 $— $0.7 $8.9 
Tax expense(2.0)
Total reclassifications for the period, net of tax$6.9 
(1)These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).
v3.25.0.1
Share-Based Compensation (Tables)
 3 Months Ended
Dec. 31, 2024
Compensation Related Costs [Abstract]  
Schedule of stock-based compensation costs
Three Months Ended
December 31,
 20242023
Share-based compensation costs $4.7 $5.2 
Less impact of income taxes1.1 1.2 
Share-based compensation costs, net of tax$3.6 $4.0 
Schedule of stock-based awards granted in the period
During the three months ended December 31, 2024, the Company made the following grants:
 
 Number of
Units
Time-based stock awards354,713 
Performance-based stock awards (maximum that can be earned)588,686 
v3.25.0.1
Fair Value Measurements (Tables)
 3 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of financial assets and liabilities at carrying value and fair value and the level within the fair value hierarchy
Carrying Value at December 31, 2024
Fair Value at December 31, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$208.0 $208.0 $— $— 
DPP receivables5.8 — 5.8 — 
Restricted cash1.0 1.0 — — 
Restricted cash for benefit plan contributions29.5 29.5 — — 
Investments in rabbi trust5.5 5.5 — — 
Derivative instruments22.3 — 22.3 — 
Liabilities:
Revolving credit facility329.0 — 329.0 — 
$200 term loan
180.0 — 180.0 — 
€185 term loan
180.9 — 180.9 — 
$350 senior unsecured notes
350.0 306.2 — — 
$375 senior unsecured notes
374.8 372.1 — — 
$500 senior unsecured notes
500.0 501.4 — — 
Derivative instruments28.1 — 28.1 — 
Contingent consideration14.6 — — 14.6 
 
 
Carrying Value at September 30, 2024
Fair Value at September 30, 2024
Using Inputs Considered as:
 Level 1Level 2Level 3
Assets:    
Cash and cash equivalents$199.3 $199.3 $— $— 
DPP receivables6.7 — 6.7 — 
Restricted cash1.1 1.1 — — 
Restricted cash for benefit plan contributions27.5 27.5 — — 
Investments in rabbi trust4.8 4.8 — — 
Derivative instruments19.0 — 19.0 — 
Liabilities:    
Revolving credit facility298.5 — 298.5 — 
$200 term loan
182.5 — 182.5 — 
€185 term loan
196.5 — 196.5 — 
$350 senior unsecured notes
350.0 312.9 — — 
$375 senior unsecured notes
374.8 373.7 — — 
$500 senior unsecured notes
500.0 509.8 — — 
Derivative instruments40.5 — 40.5 — 
Contingent consideration14.6 — — 14.6 
v3.25.0.1
Segment and Geographical Information (Tables)
 3 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of net revenue, adjusted EBITDA, and depreciation and amortization by segment and geographic location
The following tables present financial information for the Company’s reportable operating segments and significant geographical locations:
 Three Months Ended December 31,
 20242023
Net revenue
Advanced Process Solutions$511.1 $568.3 
Molding Technology Solutions195.8 205.0 
Total$706.9 $773.3 
Adjusted EBITDA (1)
Advanced Process Solutions$82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Net revenue (2)
United States$284.7 $326.9 
China81.1 91.9 
India57.1 57.9 
Germany51.1 59.1 
All other countries232.9 237.5 
Total$706.9 $773.3 
 
(1)Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP financial measure used by management to measure segment performance and make operating decisions.
(2)The Company attributes net revenue to a geography based upon the location of the end customer.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas
 December 31, 2024September 30, 2024
Total assets  
Advanced Process Solutions$3,331.7 $3,470.8 
Molding Technology Solutions1,551.2 1,600.0 
Corporate176.5 167.9 
Total$5,059.4 $5,238.7 
Tangible long-lived assets, net  
United States$184.1 $186.1 
Germany123.5 134.5 
China 34.8 37.1 
India33.9 35.6 
All other foreign business units85.2 92.0 
Total$461.5 $485.3 
Schedule of reconciliation of segment adjusted EBITDA to consolidated net income
The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income:
 Three Months Ended
December 31,
20242023
Adjusted EBITDA:
Advanced Process Solutions $82.8 $96.0 
Molding Technology Solutions27.4 32.1 
Corporate(13.1)(14.0)
Add:
Loss from discontinued operations (net of income tax expense)— (0.3)
Less:
Interest expense, net25.1 29.8 
Income tax expense6.4 10.0 
Depreciation and amortization37.9 38.8 
Pension settlement (gain) charge(1.7)8.3 
Business acquisition, divestiture, and integration costs18.1 5.6 
Inventory step-up costs— 1.5 
Restructuring and restructuring-related charges 2.4 0.6 
Consolidated net income$8.9 $19.2 
v3.25.0.1
Background and Basis of Presentation - Narrative (Details)
$ in Millions
 3 Months Ended
Feb. 01, 2023
USD ($)
Dec. 31, 2024
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Number of reportable segments | segment   2
Acquired entity subsidiary investments owned percent   100.00%
Batesville | Discontinued Operations    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Total transaction value $ 761.5  
Consideration from sale of segment, subordinated note $ 11.5  
v3.25.0.1
Revenue Recognition Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]      
Receivables from long-term manufacturing contracts, net $ 289.5   $ 302.7
Liabilities from long-term manufacturing contracts and advances 293.8   $ 315.2
Revenue recognized on long-term manufacturing contracts and advances liabilities $ 95.6 $ 116.4  
v3.25.0.1
Revenue Recognition Revenue Remaining Performance Obligation Narrative (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Amount $ 1,816.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 12 months
Remaining performance obligation expected to be recognized in the given period (as a percent) 88.00%
v3.25.0.1
Revenue Recognition by Geographic Markets (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Net revenue $ 706.9 $ 773.3
Americas    
Disaggregation of Revenue [Line Items]    
Net revenue 332.1 374.1
Asia    
Disaggregation of Revenue [Line Items]    
Net revenue 189.0 206.8
Europe, the Middle East, and Africa    
Disaggregation of Revenue [Line Items]    
Net revenue 185.8 192.4
Process Equipment Group [Member]    
Disaggregation of Revenue [Line Items]    
Net revenue 511.1 568.3
Process Equipment Group [Member] | Americas    
Disaggregation of Revenue [Line Items]    
Net revenue 229.2 264.2
Process Equipment Group [Member] | Asia    
Disaggregation of Revenue [Line Items]    
Net revenue 128.8 146.3
Process Equipment Group [Member] | Europe, the Middle East, and Africa    
Disaggregation of Revenue [Line Items]    
Net revenue 153.1 157.8
Milacron [Member]    
Disaggregation of Revenue [Line Items]    
Net revenue 195.8 205.0
Milacron [Member] | Americas    
Disaggregation of Revenue [Line Items]    
Net revenue 102.9 109.9
Milacron [Member] | Asia    
Disaggregation of Revenue [Line Items]    
Net revenue 60.2 60.5
Milacron [Member] | Europe, the Middle East, and Africa    
Disaggregation of Revenue [Line Items]    
Net revenue $ 32.7 $ 34.6
v3.25.0.1
Revenue Recognition Timing of Transfer (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Net revenue $ 706.9 $ 773.3
Point in time    
Disaggregation of Revenue [Line Items]    
Net revenue 450.9 464.6
Over time    
Disaggregation of Revenue [Line Items]    
Net revenue 256.0 308.7
Process Equipment Group [Member]    
Disaggregation of Revenue [Line Items]    
Net revenue 511.1 568.3
Process Equipment Group [Member] | Point in time    
Disaggregation of Revenue [Line Items]    
Net revenue 269.8 278.2
Process Equipment Group [Member] | Over time    
Disaggregation of Revenue [Line Items]    
Net revenue 241.3 290.1
Milacron [Member]    
Disaggregation of Revenue [Line Items]    
Net revenue 195.8 205.0
Milacron [Member] | Point in time    
Disaggregation of Revenue [Line Items]    
Net revenue 181.1 186.4
Milacron [Member] | Over time    
Disaggregation of Revenue [Line Items]    
Net revenue $ 14.7 $ 18.6
v3.25.0.1
Supplemental Balance Sheet Information - Schedule of supplemental balance sheet information (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Balance Sheet Related Disclosures [Abstract]        
Allowance for credit losses $ 13.7 $ 13.6    
Warranty reserves 46.7 47.9    
Accumulated depreciation on property, plant, and equipment 268.7 265.6    
Inventories, net:        
Raw materials and components 248.1 247.0    
Work in process 120.1 127.6    
Finished goods 153.5 150.6    
Total inventories, net 521.7 525.2    
Cash and cash equivalents 208.0 199.3 $ 198.4  
Short-term restricted cash included in other current assets 6.9   1.2  
Long-term restricted cash included in other long-term assets 23.6   0.0  
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows $ 238.5 $ 227.9 $ 199.6 $ 250.2
v3.25.0.1
Supplemental Balance Sheet Information - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Trade receivables, net $ 309.5   $ 350.1
Proceeds from Collection of Other Receivables 71.7 $ 7.2  
Equity Method Investments 12.0   9.2
Income (Loss) from Equity Method Investments $ 2.8 1.5  
TerraSource Holdings, LLC      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Equity Method Investment, Ownership Percentage 46.00%    
Trade Accounts Receivable      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Proceeds from Sale of Other Receivables $ 70.8 $ 7.2  
Trade receivables, net 28.5   34.2
Supplier Finance Program      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Contractual Obligation 14.4   16.0
Trade receivables, net $ 2.2   $ 3.1
v3.25.0.1
Supplemental Balance Sheet Information - DPP Receivables (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Receivable Roll Forward [Roll Forward]    
Beginning DPP receivables balance $ 6.7 $ 0.0
Non-cash additions to DPP receivables 9.2 0.0
Collection of deferred purchase price receivables (10.1) 0.0
Ending DPP receivables balance $ 5.8 $ 0.0
v3.25.0.1
Leases - Narrative (Details) - USD ($)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease expense $ 10.5 $ 8.5
v3.25.0.1
Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Leases [Abstract]    
Operating lease right-of-use assets, net $ 157.8 $ 168.7
Other current liabilities 20.5 22.0
Operating lease liabilities 131.8 141.1
Total operating lease liabilities $ 152.3 $ 163.1
Weighted-average remaining lease term (in years) 10 years 1 month 6 days 10 years 3 months 18 days
Weighted-average discount rate 6.30% 6.30%
v3.25.0.1
Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Leases [Abstract]    
2025 (excluding the three months ended December 31, 2024) $ 21.4  
2026 25.9  
2027 23.0  
2028 20.8  
2029 19.2  
Thereafter 111.4  
Total lease payments 221.7  
Less: imputed interest (69.4)  
Total present value of lease payments $ 152.3 $ 163.1
v3.25.0.1
Leases - Schedule of Supplemental Statement of Cash Flow Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Cash paid for amounts included in the measurement of operating lease liabilities $ 8.0 $ 6.8
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities 4.6 4.9
Operating leases acquired in business combinations $ 0.0 $ 3.5
v3.25.0.1
Intangible Assets and Goodwill - Narrative (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Advanced Process Solutions    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net $ 658.6 $ 693.0
Indefinite-lived assets: 108.8 112.3
Molding Technology Solutions    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Net 369.7 388.3
Indefinite-lived assets: $ 85.1 $ 85.1
Minimum    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life 3 years  
Maximum    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life 21 years  
v3.25.0.1
Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Sep. 30, 2024
Intangible Assets [Line Items]    
Cost $ 1,574.5 $ 1,614.7
Accumulated Amortization (539.0) (526.2)
Total 1,768.4 1,812.1
Trade names    
Intangible Assets [Line Items]    
Indefinite-lived assets: 193.9 197.4
Customer relationships    
Intangible Assets [Line Items]    
Cost 1,278.6 1,316.9
Accumulated Amortization (386.8) (379.4)
Trade names    
Intangible Assets [Line Items]    
Cost 189.3 192.3
Accumulated Amortization (101.8) (100.9)
Software    
Intangible Assets [Line Items]    
Cost 56.4 53.0
Accumulated Amortization (38.9) (35.3)
Trade names    
Intangible Assets [Line Items]    
Cost 50.2 52.5
Accumulated Amortization $ (11.5) $ (10.6)
v3.25.0.1
Intangible Assets and Goodwill - Goodwill (Details)
$ in Millions
 3 Months Ended
Dec. 31, 2024
USD ($)
Goodwill [Roll Forward]  
Balance at the beginning of the period $ 1,835.7
Foreign currency adjustments (56.6)
Balance at the end of the period 1,779.1
Process Equipment Group [Member]  
Goodwill [Roll Forward]  
Balance at the beginning of the period 1,430.2
Foreign currency adjustments (48.7)
Balance at the end of the period 1,381.5
Milacron [Member]  
Goodwill [Roll Forward]  
Balance at the beginning of the period 405.5
Foreign currency adjustments (7.9)
Balance at the end of the period $ 397.6
v3.25.0.1
Financing Agreements - Schedule of borrowings (Details)
Dec. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Feb. 14, 2024
USD ($)
Jun. 21, 2023
EUR (€)
Jun. 08, 2022
USD ($)
Mar. 03, 2021
USD ($)
Sep. 25, 2019
USD ($)
Debt Instrument [Line Items]              
Total debt $ 1,905,900,000 $ 1,893,000,000          
Current portion of long-term debt 20,900,000 20,600,000          
Long-term debt 1,885,000,000 1,872,400,000          
Former Credit Agreement | Revolving Credit Facility              
Debt Instrument [Line Items]              
Line of credit facility, maximum borrowing capacity         $ 1,000,000,000    
$375 senior unsecured notes (2)              
Debt Instrument [Line Items]              
Debt instrument, face amount           $ 350,000,000  
$1,000 revolving credit facility (excluding outstanding letters of credit)              
Debt Instrument [Line Items]              
Total debt 329,000,000.0 298,500,000          
$1,000 revolving credit facility (excluding outstanding letters of credit) | Fourth Amended And Restated Credit Agreement | $200 term loan              
Debt Instrument [Line Items]              
Debt Instrument, Delayed Draw, Amount         $ 200,000,000    
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan              
Debt Instrument [Line Items]              
Long-Term Line of Credit | €       € 185,000,000      
$200 term loan              
Debt Instrument [Line Items]              
Total debt 180,000,000.0 182,500,000          
$500 senior unsecured notes (1)              
Debt Instrument [Line Items]              
Total debt 495,000,000.0 494,600,000          
Debt Issuance Costs, Line of Credit Arrangements, Gross 5,000,000.0 5,400,000          
$400 senior unsecured notes (2) | Twenty Twenty Four Senior Unsecured Notes Due February Twenty Twenty Nine              
Debt Instrument [Line Items]              
Debt instrument, face amount     $ 500,000,000        
$400 senior unsecured notes (2) | 2019 Notes              
Debt Instrument [Line Items]              
Debt instrument, face amount             $ 375,000,000
$375 senior unsecured notes (2)              
Debt Instrument [Line Items]              
Total debt 373,800,000 373,600,000          
Debt Issuance Costs, Line of Credit Arrangements, Gross 1,000,000.0 1,200,000          
$350 senior unsecured notes (3)              
Debt Instrument [Line Items]              
Total debt 347,200,000 347,100,000          
Debt Issuance Costs, Line of Credit Arrangements, Gross 2,800,000 2,900,000          
Term Loan | Term Loan 225 Million              
Debt Instrument [Line Items]              
Total debt 180,900,000 196,500,000          
Notes Payable, Other Payables              
Debt Instrument [Line Items]              
Total debt 0 $ 200,000          
$200 Term Loan And 185 Term Loan              
Debt Instrument [Line Items]              
Debt Issuance Costs, Line of Credit Arrangements, Gross $ 5,000,000.0            
v3.25.0.1
Financing Agreements - Narrative (Details)
 3 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
Sep. 30, 2024
USD ($)
Jun. 21, 2023
EUR (€)
Jun. 08, 2022
USD ($)
Debt Instrument [Line Items]          
Current borrowing capacity $ 424,300,000        
L/G Facility Agreement Amendment          
Debt Instrument [Line Items]          
Debt Issuance Costs, Line of Credit Arrangements, Gross $ 1,400,000        
$200 term loan | Debt Instrument, Tranche One          
Debt Instrument [Line Items]          
Weighted-average interest rates 6.69%        
$200 term loan | Debt Instrument, Tranche Two          
Debt Instrument [Line Items]          
Weighted-average interest rates 5.60%        
185 Euro Term Loan | Debt Instrument, Tranche One          
Debt Instrument [Line Items]          
Weighted-average interest rates 5.05% 5.60%      
$1,000 revolving credit facility (excluding outstanding letters of credit)          
Debt Instrument [Line Items]          
Letters of credit outstanding, amount $ 17,700,000        
Line of credit facility, remaining borrowing capacity $ 653,300,000        
Weighted average facility fee 0.24% 0.20%      
$1,000 revolving credit facility (excluding outstanding letters of credit) | Debt Instrument, Tranche One          
Debt Instrument [Line Items]          
Weighted-average interest rates 4.96%        
$1,000 revolving credit facility (excluding outstanding letters of credit) | Debt Instrument, Tranche Two          
Debt Instrument [Line Items]          
Weighted-average interest rates 5.84%        
$1,000 revolving credit facility (excluding outstanding letters of credit) | Fourth Amended And Restated Credit Agreement | $200 term loan          
Debt Instrument [Line Items]          
Debt Instrument, Delayed Draw, Amount         $ 200,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan          
Debt Instrument [Line Items]          
Long-Term Line of Credit | €       € 185,000,000  
$350 senior unsecured notes (3)          
Debt Instrument [Line Items]          
Debt Issuance Costs, Line of Credit Arrangements, Gross $ 2,800,000   $ 2,900,000    
Other Financing Agreements          
Debt Instrument [Line Items]          
Line of credit facility, maximum borrowing capacity 561,300,000   594.3    
Line of credit facility, amount utilized for bank guarantees 331,700,000   400.2    
$500 senior unsecured notes (1)          
Debt Instrument [Line Items]          
Debt Issuance Costs, Line of Credit Arrangements, Gross $ 5,000,000.0   $ 5,400,000    
v3.25.0.1
Retirement Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]    
Pension settlement (gain) charge $ 1.7 $ (8.3)
U.S. Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service costs 0.0 0.0
Interest costs 0.2 2.0
Expected return on plan assets 0.0 (2.7)
Amortization of net loss (gain) 0.0 0.1
Pension settlement (gain) charge 1.7 (8.3)
Net periodic pension (benefit) cost (1.5) 7.7
Non-U.S. Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service costs 0.7 0.5
Interest costs 0.8 1.1
Expected return on plan assets (0.3) (0.4)
Amortization of net loss (gain) (0.2) (0.2)
Pension settlement (gain) charge 0.0 0.0
Net periodic pension (benefit) cost $ 1.0 $ 1.0
v3.25.0.1
Retirement Benefits - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Retirement Benefits [Abstract]    
Defined contribution plan expense $ 3.1 $ 2.9
v3.25.0.1
Income Taxes (Details)
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Effective income tax rate 41.80% 33.90%
v3.25.0.1
Earnings Per Share - Narrative (Details) - shares
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Antidilutive securities excluded from computation of earnings per share [Line Items]    
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 900,000 600,000
Performance-based stock awards (maximum that can be earned)    
Antidilutive securities excluded from computation of earnings per share [Line Items]    
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 630,000 440,000
v3.25.0.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]    
Income from continuing operations $ 8.9 $ 19.5
Less: Net income attributable to noncontrolling interests 2.5 2.0
Income from continuing operations attributable to Hillenbrand $ 6.4 $ 17.5
Weighted average shares outstanding (basic) 70.6 70.3
Effect of dilutive stock options and other unvested equity awards (in millions) 0.0 0.2
Weighted-average shares outstanding (diluted - in millions) 70.6 70.5
Income from continuing operations attributable to Hillenbrand (in dollars per share) $ 0.09 $ 0.25
Income from continuing operations attributable to Hillenbrand (in dollars per share) $ 0.09 $ 0.25
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.9 0.6
v3.25.0.1
Other Comprehensive Income (Loss) - Schedule of changes in accumulated other comprehensive income (loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]    
Balance at the beginning of the period $ (96.6)  
Other comprehensive income before reclassifications    
Before tax amount (36.3) $ 49.2
Tax benefit 0.4 0.1
After tax amount (35.9) 49.3
Amounts reclassified from accumulated other comprehensive loss (2) 0.7 6.9
Total changes in other comprehensive (loss) income, net of tax (35.2) 56.2
Balance at the end of the period (131.2)  
Pension and Postretirement    
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]    
Balance at the beginning of the period (15.6) (34.5)
Other comprehensive income before reclassifications    
Before tax amount 1.1 (0.4)
Tax benefit (0.3) 0.2
After tax amount 0.8 (0.2)
Amounts reclassified from accumulated other comprehensive loss (2) 0.0 6.2
Total changes in other comprehensive (loss) income, net of tax 0.8 6.0
Balance at the end of the period (14.8) (28.5)
Currency Translation (1)    
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]    
Balance at the beginning of the period (55.4) (107.1)
Other comprehensive income before reclassifications    
Before tax amount (63.3) 49.3
Tax benefit 0.0 0.0
After tax amount (63.3) 49.3
Amounts reclassified from accumulated other comprehensive loss (2) 0.0 0.0
Total changes in other comprehensive (loss) income, net of tax (63.3) 49.3
Balance at the end of the period (118.7) (57.8)
Net Unrealized (Loss) Gain on Derivative Instruments    
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]    
Balance at the beginning of the period (25.6) (5.5)
Other comprehensive income before reclassifications    
Before tax amount 26.5 0.3
Tax benefit 0.7 (0.1)
After tax amount 27.2 0.2
Amounts reclassified from accumulated other comprehensive loss (2) 0.7 0.7
Total changes in other comprehensive (loss) income, net of tax 27.9 0.9
Balance at the end of the period 2.3 (4.6)
Total Attributable to Hillenbrand, Inc.    
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]    
Balance at the beginning of the period (96.6) (147.1)
Other comprehensive income before reclassifications    
Before tax amount (35.7) 49.2
Tax benefit 0.4 0.1
After tax amount (35.3) 49.3
Amounts reclassified from accumulated other comprehensive loss (2) 0.7 6.9
Total changes in other comprehensive (loss) income, net of tax (34.6) 56.2
Balance at the end of the period (131.2) (90.9)
Noncontrolling Interests    
Other comprehensive income before reclassifications    
Before tax amount (0.6) 0.0
Tax benefit 0.0 0.0
After tax amount (0.6) 0.0
Amounts reclassified from accumulated other comprehensive loss (2) 0.0 0.0
Total changes in other comprehensive (loss) income, net of tax $ (0.6) $ 0.0
v3.25.0.1
Other Comprehensive Income (Loss) - Schedule of reclassifications (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Affected Line in the Consolidated Statement of Operations:    
Net revenue $ 706.9 $ 773.3
Cost of Goods and Services Sold (471.9) (522.3)
Tax expense (6.4) (10.0)
Total reclassifications for the period, net of tax 0.7 6.9
Amortization of Pension and Postretirement    
Affected Line in the Consolidated Statement of Operations:    
Total reclassifications for the period, net of tax 0.0 6.2
Loss (Gain) on Derivative Instruments    
Affected Line in the Consolidated Statement of Operations:    
Total reclassifications for the period, net of tax 0.7 0.7
Reclassifications out of accumulated other comprehensive income (loss)    
Affected Line in the Consolidated Statement of Operations:    
Net revenue 0.3 (0.1)
Operating expenses 0.5 (8.7)
Cost of Goods and Services Sold   0.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 0.8 8.9
Tax expense (0.1) (2.0)
Total reclassifications for the period, net of tax 0.7 6.9
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Net Loss Recognized [Member]    
Affected Line in the Consolidated Statement of Operations:    
Net revenue 0.0 0.0
Operating expenses 0.0 (8.2)
Cost of Goods and Services Sold   0.0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 0.0 8.2
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Prior Service Cost Recognized [Member]    
Affected Line in the Consolidated Statement of Operations:    
Net revenue 0.0 0.0
Operating expenses 0.0 0.0
Cost of Goods and Services Sold   0.0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 0.0 0.0
Reclassifications out of accumulated other comprehensive income (loss) | Loss (Gain) on Derivative Instruments    
Affected Line in the Consolidated Statement of Operations:    
Net revenue 0.3 (0.1)
Operating expenses 0.5 (0.5)
Cost of Goods and Services Sold   0.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax $ 0.8 $ 0.7
v3.25.0.1
Share-Based Compensation - Schedule of stock-based compensation costs (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Compensation Related Costs [Abstract]    
Share-based compensation costs $ 4.7 $ 5.2
Less impact of income taxes 1.1 1.2
Share-based compensation costs, net of tax $ 3.6 $ 4.0
v3.25.0.1
Share-Based Compensation - Schedule of stock-based awards granted (Details)
 3 Months Ended
Dec. 31, 2024
shares
Time-based stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock awards granted in period (in shares) 354,713
Performance-based stock awards (maximum that can be earned)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock awards granted in period (in shares) 588,686
v3.25.0.1
Share-Based Compensation - Narrative (Details)
 3 Months Ended
Dec. 31, 2024
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Award vesting period (in years) 3 years
Time-based stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Equity instruments other than options, grant date fair value (in dollars per share) $ 33.62
Performance-based stock awards (maximum that can be earned)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Equity instruments other than options, grant date fair value (in dollars per share) $ 40.06
Performance-based stock awards granted, number of units (in shares) | shares 294,386
v3.25.0.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Molding Technology Solutions    
Commitments and Contingencies    
Loss Contingency Accrual $ 11.2 $ 11.2
General claims and lawsuits | Minimum    
Commitments and Contingencies    
Deductibles and self-insured retentions per occurrence or per claim $ 0.5  
v3.25.0.1
Fair Value Measurements - Schedule of financial assets and liabilities (Details)
 3 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
Feb. 14, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 01, 2023
USD ($)
Jun. 21, 2023
USD ($)
Jun. 21, 2023
EUR (€)
Mar. 03, 2021
USD ($)
Sep. 25, 2019
USD ($)
Assets:                    
Cash and cash equivalents $ 208,000,000.0                  
Receivables, Fair Value Disclosure 5,800,000 $ 0 $ 6,700,000   $ 0          
Restricted Cash 1,000,000.0   1,100,000              
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 29,500,000   27,500,000              
Investments in rabbi trust 5,500,000   4,800,000              
Derivative instruments 22,300,000   19,000,000.0              
Liabilities:                    
Derivative instruments 28,100,000   40,500,000              
Interest expense, net 25,100,000 29,800,000                
Reported Value Measurement                    
Assets:                    
Receivables, Fair Value Disclosure 5,800,000   6,700,000              
Liabilities:                    
Business Combination, Contingent Consideration, Liability 14,600,000   14,600,000              
Schenck Process Food and Performance Materials                    
Liabilities:                    
Business Combination, Contingent Consideration, Liability           $ 14,600,000        
$375 senior unsecured notes (2)                    
Liabilities:                    
Debt instrument, face amount                 $ 350,000,000  
Foreign Exchange Forward                    
Assets:                    
Derivative instruments 262,400,000   172,500,000              
Cross Currency Interest Rate Contract                    
Assets:                    
Derivative instruments 691,900,000   727,800,000              
Liabilities:                    
Interest expense, net 3,200,000 $ 0.0                
Level 1                    
Assets:                    
Cash and cash equivalents 208,000,000.0   199,300,000              
Receivables, Fair Value Disclosure 0   0              
Restricted Cash 1,000,000.0   1,100,000              
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 29,500,000   27,500,000              
Investments in rabbi trust 5,500,000   4,800,000              
Derivative instruments 0   0              
Liabilities:                    
Derivative instruments 0   0              
Business Combination, Contingent Consideration, Liability 0   0              
Level 2                    
Assets:                    
Cash and cash equivalents 0   0              
Receivables, Fair Value Disclosure 5,800,000   6,700,000              
Restricted Cash 0   0              
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 0   0              
Investments in rabbi trust 0   0              
Derivative instruments 22,300,000   19,000,000.0              
Liabilities:                    
Derivative instruments 28,100,000   40,500,000              
Business Combination, Contingent Consideration, Liability 0   0              
Level 3                    
Assets:                    
Cash and cash equivalents 0   0              
Receivables, Fair Value Disclosure 0   0              
Restricted Cash 0   0              
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 0   0              
Investments in rabbi trust 0   0              
Derivative instruments 0   0              
Liabilities:                    
Derivative instruments 0   0              
Business Combination, Contingent Consideration, Liability 14,600,000   14,600,000              
$1,000 revolving credit facility (excluding outstanding letters of credit)                    
Liabilities:                    
Debt instruments 329,000,000.0   298,500,000              
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan                    
Liabilities:                    
Long-Term Line of Credit | €               € 185,000,000    
$1,000 revolving credit facility (excluding outstanding letters of credit) | $200 term loan                    
Liabilities:                    
Long-Term Line of Credit             $ 200,000,000      
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 1                    
Liabilities:                    
Debt instruments 0   0              
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 2                    
Liabilities:                    
Debt instruments 329,000,000.0   298,500,000              
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 3                    
Liabilities:                    
Debt instruments 0   0              
$200 term loan                    
Liabilities:                    
Debt instruments 180,000,000.0   182,500,000              
$200 term loan | Level 1                    
Liabilities:                    
Debt instruments 0   0              
$200 term loan | Level 2                    
Liabilities:                    
Debt instruments 180,000,000.0   182,500,000              
$200 term loan | Level 3                    
Liabilities:                    
Debt instruments 0   0              
2021 Notes                    
Liabilities:                    
Debt instruments 350,000,000.0   350,000,000.0              
2021 Notes | Level 1                    
Liabilities:                    
Debt instruments 306,200,000   312,900,000              
2021 Notes | Level 2                    
Liabilities:                    
Debt instruments 0   0              
2021 Notes | Level 3                    
Liabilities:                    
Debt instruments 0   0              
2020 Notes                    
Liabilities:                    
Debt instruments 374,800,000   374,800,000              
2020 Notes | Level 1                    
Liabilities:                    
Debt instruments 372,100,000   373,700,000              
2020 Notes | Level 2                    
Liabilities:                    
Debt instruments 0   0              
2020 Notes | Level 3                    
Liabilities:                    
Debt instruments 0   0              
2019 Notes                    
Liabilities:                    
Debt instruments 500,000,000.0   500,000,000.0              
2019 Notes | Level 1                    
Liabilities:                    
Debt instruments 501,400,000   509,800,000              
2019 Notes | Level 2                    
Liabilities:                    
Debt instruments 0   0              
2019 Notes | Level 3                    
Liabilities:                    
Debt instruments 0   0              
One Hundred Ninety Five Million Euro Term Loan                    
Liabilities:                    
Debt instruments 180,900,000   196,500,000              
One Hundred Ninety Five Million Euro Term Loan | Level 1                    
Liabilities:                    
Debt instruments 0   0              
One Hundred Ninety Five Million Euro Term Loan | Level 2                    
Liabilities:                    
Debt instruments 180,900,000   196,500,000              
One Hundred Ninety Five Million Euro Term Loan | Level 3                    
Liabilities:                    
Debt instruments $ 0   $ 0              
$400 senior unsecured notes (2) | 2019 Notes                    
Liabilities:                    
Debt instrument, face amount                   $ 375,000,000
$400 senior unsecured notes (2) | Twenty Twenty Four Senior Unsecured Notes Due February Twenty Twenty Nine                    
Liabilities:                    
Debt instrument, face amount       $ 500,000,000            
v3.25.0.1
Segment and Geographical Information - Schedule of net revenue and assets by segment (Details)
$ in Millions
 3 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
Segment Reporting [Abstract]      
Number of reportable segments | segment 2    
Number of operating segments | segment 2    
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue $ 706.9 $ 773.3  
Total assets 5,059.4   $ 5,238.7
Property, plant, and equipment, net 461.5   485.3
United States      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 284.7 326.9  
Property, plant, and equipment, net 184.1   186.1
GERMANY      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 81.1 91.9  
Property, plant, and equipment, net 123.5   134.5
CHINA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 57.1 57.9  
Property, plant, and equipment, net 34.8   37.1
INDIA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 51.1 59.1  
Property, plant, and equipment, net 33.9   35.6
All other countries      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 232.9 237.5  
Property, plant, and equipment, net 85.2   92.0
Corporate      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Adjusted EBITDA (1) (13.1) (14.0)  
Total assets 176.5   167.9
Advanced Process Solutions      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 511.1 568.3  
Advanced Process Solutions | Operating segments      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Adjusted EBITDA (1) 82.8 96.0  
Total assets 3,331.7   3,470.8
Milacron [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net revenue 195.8 205.0  
Milacron [Member] | Operating segments      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Adjusted EBITDA (1) 27.4 $ 32.1  
Total assets $ 1,551.2   $ 1,600.0
v3.25.0.1
Segment and Geographical Information - Schedule of reconciliation of segment (Details 2) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment and Geographical Information    
Loss from discontinued operations (net of income tax expense) $ 0.0 $ (0.3)
Interest expense, net 25.1 29.8
Income tax expense 6.4 10.0
Depreciation and amortization 37.9 38.8
Pension settlement (gain) charge (1.7) 8.3
Business acquisition, development, and integration costs 18.1 5.6
Inventory step-up costs 0.0 1.5
Inventory step-up 2.4 0.6
Income from continuing operations 8.9 19.2
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]    
Segment and Geographical Information    
Adjusted EBITDA (1) (13.1) (14.0)
Advanced Process Solutions | Operating segments    
Segment and Geographical Information    
Adjusted EBITDA (1) 82.8 96.0
Milacron [Member] | Operating segments    
Segment and Geographical Information    
Adjusted EBITDA (1) $ 27.4 $ 32.1
v3.25.0.1
Subsequent Events (Details) - Subsequent Event - Disposal Group, Held-for-Sale, Not Discontinued Operations - Milacron Injection Molding Business
$ in Millions
Feb. 05, 2025
USD ($)
Subsequent Event [Line Items]  
Percentage of business sold 51.00%
Ownership interest after disposal 49.00%
Business disposal, expected consideration $ 287.0
Hillenbrand (NYSE:HI)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Hillenbrand Charts.
Hillenbrand (NYSE:HI)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Hillenbrand Charts.